{"gene":"UBASH3A","run_date":"2026-04-28T21:43:00","timeline":{"discoveries":[{"year":2001,"finding":"UBASH3A (also called TULA/STS-2) was identified as a novel gene on chromosome 21q22.3 encoding a 661-amino-acid protein with a unique combination of an SH3 domain, a ubiquitin-associated (UBA) domain, and a novel phosphoglycerate mutase-like domain containing a nuclear localization signal. Expression was found to be restricted to spleen, peripheral blood leukocytes, and bone marrow, suggesting lymphoid-specific expression.","method":"cDNA cloning, domain analysis, semi-quantitative RT-PCR across tissues","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 1-2 — original gene isolation with domain characterization; foundational paper","pmids":["11281453"],"is_preprint":false},{"year":2004,"finding":"Sts-2 (UBASH3A) and Sts-1 negatively regulate TCR signaling: T cells from Sts-1/2 double-knockout mice are hyperresponsive to TCR stimulation, exhibiting increased ZAP-70 phosphorylation (including ubiquitylated forms) and hyperactivation of downstream signaling proteins, leading to increased cytokine production and increased susceptibility to autoimmunity in an EAE mouse model.","method":"Double-knockout mouse generation, T cell stimulation assays, immunoblotting for phospho-ZAP-70, cytokine production assays, EAE model","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple readouts in vivo and in vitro","pmids":["14738763"],"is_preprint":false},{"year":2004,"finding":"TULA (UBASH3A/STS-2) binds directly to c-Cbl via its SH3 domain, binds mono-ubiquitin and EGFR/ubiquitin chimera via its UBA domain, and inhibits c-Cbl-mediated downregulation of EGFR in 293T cells. TULA overexpression in Jurkat T cells upregulates ZAP-70 kinase activity and NF-AT transcription factor activity, suggesting it counteracts c-Cbl-mediated suppression of protein tyrosine kinases by promoting ubiquitylation and degradation of c-Cbl.","method":"Affinity chromatography, mass spectrometry, co-immunoprecipitation, co-expression in 293T cells, Jurkat T-cell overexpression/knockdown assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP plus functional cell-based assays in single lab","pmids":["15107835"],"is_preprint":false},{"year":2004,"finding":"TULA (UBASH3A/STS-2) and Sts-1 are recruited into activated EGFR complexes upon ligand stimulation, inhibit receptor internalization (reducing the number of EGFR-containing endocytic vesicles), block receptor degradation, and thereby prolong activation of mitogenic signaling pathways. The SH3 domain mediates Cbl binding; the UBA domain binds mono-ubiquitin and EGFR/Ub chimera; the PGM domain mediates Sts-1/2 oligomerization.","method":"Co-immunoprecipitation, dominant-negative interference, fluorescence microscopy, endocytosis assays, cell proliferation and transformation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, domain-function mapping, confirmed in multiple cell systems","pmids":["15159412"],"is_preprint":false},{"year":2007,"finding":"TULA (UBASH3A) inhibits clathrin-dependent endocytosis of transferrin and LDL, and clathrin-independent but dynamin-dependent endocytosis of CD59 and MHC-I, but does not affect dynamin-independent uptake of ricin. TULA co-immunoprecipitates and colocalizes with dynamin, and the inhibitory effect on endocytosis is counteracted by overexpression of dynamin, indicating that the SH3 domain of TULA sequesters dynamin via its proline-rich sequences.","method":"Endocytosis assays (Tf, LDL, CD59, MHC-I, ricin uptake), co-immunoprecipitation of TULA and dynamin, rescue experiments with dynamin overexpression, domain mapping","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 — multiple cargo types tested, rescue experiments, mechanistic domain assignment; replicated across multiple cargo types","pmids":["17382318"],"is_preprint":false},{"year":2007,"finding":"TULA (UBASH3A) promotes T cell apoptosis independently of TCR/CD3 signaling and caspase activity. Mass spectrometry identified apoptosis-inducing factor (AIF) as a TULA-interacting protein; RNAi knockdown of AIF abolishes the apoptotic effect of TULA. Subcellular localization and functional analysis of TULA mutants indicate that TULA enhances AIF-mediated caspase-independent apoptosis, likely by facilitating AIF interactions with co-factors.","method":"Mass spectrometry-based protein interaction analysis, siRNA knockdown of AIF, apoptosis assays (caspase-independent), subcellular localization, TULA mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — MS-identified interaction validated by functional rescue (siRNA), multiple orthogonal approaches in single study","pmids":["17709377"],"is_preprint":false},{"year":2007,"finding":"TULA (UBASH3A/STS-2) proteins bind to ABCE-1 (also known as RLI/HP68, a host factor for HIV-1 assembly) as identified by mass spectrometry, and substantially inhibit production of both sub-genomic and full-length HIV-1 viral particles. The anti-HIV-1 effect requires the UBA domain of TULA, and ABCE-1 appears to recruit TULA to sites of HIV-1 assembly where it disrupts ubiquitylation-dependent steps of the HIV-1 life cycle.","method":"Mass spectrometry identification of TULA-associated proteins, HIV-1 production assays, UBA domain deletion mutants, co-localization studies","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2-3 — MS-identified interaction, UBA domain mutagenesis, functional HIV production assay; single lab","pmids":["18006034"],"is_preprint":false},{"year":2006,"finding":"Sts-2 (UBASH3A) undergoes monoubiquitination via an intramolecular mechanism: the UBA domain of Sts-2 binds to the attached ubiquitin moiety, preventing Sts-2 from binding in trans to ubiquitinated targets. Permanent monoubiquitination (mimicked by ubiquitin fusion to the C-terminus) impairs the ability of Sts-2 to regulate trafficking of ubiquitinated receptors. The in vivo monoubiquitination site of Sts-2 was mapped, and its mutation enhances Sts-2-mediated effects on EGFR downregulation.","method":"Monoubiquitination site mapping, ubiquitin fusion constructs, co-immunoprecipitation, EGFR trafficking assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic mapping of PTM site with functional consequences, multiple orthogonal approaches","pmids":["16429130"],"is_preprint":false},{"year":2007,"finding":"Sts-2 (UBASH3A), in contrast to Sts-1, stabilizes EGFR in a signaling-competent (phosphorylated) state: Sts-2 UBA domain contributes to receptor stabilization, but the PGM domain of Sts-2 lacks the dephosphorylation activity toward EGFR that Sts-1 PGM possesses. Thus Sts-1 and Sts-2 inhibit EGFR degradation via mechanistically distinct pathways.","method":"Domain swap and deletion experiments, EGFR phosphorylation and degradation assays, comparison of Sts-1 and Sts-2 PGM phosphatase activity toward EGFR","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — comparative domain analysis with functional readouts; distinguishes Sts-2 mechanism from Sts-1","pmids":["17880946"],"is_preprint":false},{"year":2007,"finding":"Sts-2 (UBASH3A) undergoes E3-independent monoubiquitination: the UBA domain directly cooperates with Ub-charged E2 enzymes to promote monoubiquitination in the absence of E3 ligases. FRET and siRNA studies confirmed that Ub-loaded E2 and Sts-2 interact in cells and that E2 enzymes are essential for their monoubiquitination in vivo.","method":"E3-independent ubiquitination assays in vitro, FRET, siRNA knockdown, in vivo ubiquitination assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution plus in vivo validation with FRET and siRNA","pmids":["17588522"],"is_preprint":false},{"year":2008,"finding":"TULA (UBASH3A/STS-2) has negligible phosphatase activity toward tyrosine-phosphorylated Syk compared to TULA-2. Overexpression of TULA increases Syk tyrosine phosphorylation in cells co-transfected with Syk, suggesting TULA acts as a dominant-negative inhibitor of TULA-2-dependent Syk dephosphorylation. Thus TULA and TULA-2 exert opposing effects on Syk phosphorylation.","method":"In vitro phosphatase assays with Syk substrate, co-transfection overexpression in cells, immunoblotting for phospho-Syk, dominant-negative mutant analysis","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro phosphatase assays plus cell-based overexpression; single lab","pmids":["18189269"],"is_preprint":false},{"year":2009,"finding":"The crystal structure of the PGM (2H-phosphatase) domain of Sts-2 (UBASH3A) was solved in apo, tungstate-bound, and phosphate-bound forms, showing strong structural similarity to Sts-1 PGM including conservation of all catalytic residues. The active site shows pH optimum at 5.0 (acid-dependent phosphatase). Non-conserved residues Gln372, Ala446, Glu481, Ser552, and Ser582 account for the reduced activity relative to Sts-1: mutating these to Sts-1 equivalents substantially increases Sts-2 PGM activity.","method":"X-ray crystallography (apo, tungstate-bound, phosphate-bound structures), phosphatase kinetics, site-directed mutagenesis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structures plus mutagenesis defining catalytic mechanism and specificity determinants","pmids":["19196006"],"is_preprint":false},{"year":2009,"finding":"Crystal structures of the Sts-2 (UBASH3A) PGM domain in its phosphorylated form and bound to vanadate (transition-state analogue) reveal that His366 is the nucleophilic residue transiently phosphorylated during catalysis. The V-NE2 bond length (2.25 Å) indicates a partially associative reaction mechanism. Glu476 plays a role in activating a uniquely positioned water molecule for dephosphorylation.","method":"X-ray crystallography of phospho-intermediate and VO3-bound transition state analogue, bond length analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structures of reaction intermediates directly defining catalytic mechanism","pmids":["19627098"],"is_preprint":false},{"year":2010,"finding":"TULA-1 (UBASH3A) showed no detectable phosphatase activity toward any phosphotyrosyl peptides in a combinatorial library screen, in contrast to TULA-2 which showed activity toward two peptide classes. This establishes that UBASH3A lacks significant intrinsic phosphatase activity against the substrates tested.","method":"Combinatorial phosphotyrosyl peptide library screening, kinetic analysis of representative peptide substrates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic in vitro assay across large peptide library; clearly negative result for UBASH3A","pmids":["20670933"],"is_preprint":false},{"year":2011,"finding":"Sts-2 (UBASH3A) regulates the level of tyrosine phosphorylation on ZAP-70 in T cells. The PGM domain of Sts-2 has clear but weak phosphatase activity detectable with appropriate substrates. Residues Glu-481, Ser-552, and Ser-582 are specificity determinants: a triple mutant converting these to their Sts-1 counterparts substantially increases Sts-2 phosphatase activity, suggesting the two homologs cooperate independently to set the TCR activation threshold.","method":"T cell phosphorylation assays, in vitro phosphatase activity with new substrates, site-directed mutagenesis of active site residues","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro enzyme assays with mutagenesis plus cell-based phosphorylation readouts","pmids":["21393235"],"is_preprint":false},{"year":2015,"finding":"Nrdp1 E3 ligase mediates K33-linked polyubiquitination of ZAP-70 and promotes its dephosphorylation by Sts-1 and Sts-2 (UBASH3A), thereby terminating early TCR signaling in CD8+ T cells. Nrdp1 physically interacts with ZAP-70 and with both Sts proteins, linking K33-ubiquitin modification of ZAP-70 to Sts-mediated dephosphorylation.","method":"K33 polyubiquitination assays, co-immunoprecipitation, Nrdp1 knockout mice, T cell activation assays, ZAP-70 phosphorylation analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo KO plus biochemical reconstitution of ubiquitin-linked dephosphorylation, replicated with multiple approaches","pmids":["26390156"],"is_preprint":false},{"year":2017,"finding":"UBASH3A attenuates NF-κB signaling downstream of TCR stimulation by specifically suppressing activation of the IκB kinase (IKK) complex. Novel interactions of UBASH3A with non-degradative polyubiquitin chains, TAK1, and NEMO were identified, suggesting an ubiquitin-dependent mechanism of NF-κB pathway regulation. T1D risk alleles at rs11203203 and rs80054410 increase UBASH3A expression in primary CD4+ T cells upon TCR stimulation, resulting in reduced IKK activation and decreased IL-2 gene expression.","method":"siRNA knockdown and overexpression in primary human CD4+ T cells, IKK complex activity assays, co-immunoprecipitation of UBASH3A with polyubiquitin chains/TAK1/NEMO, IL-2 production assays, allele-specific expression studies","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods (Co-IP, kinase assay, gene expression) in primary human T cells; functional allele-specific validation","pmids":["28607106"],"is_preprint":false},{"year":2017,"finding":"Human Sts-2 (UBASH3A) histidine phosphatase domain (Sts-2HP) crystal structure was solved to 2.4 Å with sulfate bound; steady-state kinetics confirm that Sts-2HP has significantly lower phosphatase activity than Sts-1HP (human proteins behave similarly to mouse). The PHPS1 inhibitor (known SHP-1 inhibitor) inhibits Sts-1 with Ki = 1.05 μM, and human Sts-1 shows robust phosphatase activity against ZAP-70 in a cell-based assay.","method":"X-ray crystallography of human Sts-2HP, steady-state kinetic analysis, inhibitor testing, cell-based ZAP-70 dephosphorylation assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure of human protein with kinetic characterization and cell-based validation","pmids":["28759203"],"is_preprint":false},{"year":2018,"finding":"UBASH3A noncoding variant rs1893592 plays a novel role in T1D: its minor allele is associated with reduced overall UBASH3A mRNA levels and increased proportion of an intron-9-retaining, non-functional transcript in primary CD4+ T cells upon TCR stimulation. This reduction in UBASH3A protein leads to increased IL-2 secretion, demonstrating that noncoding variants regulate UBASH3A expression and thereby T cell function.","method":"Haplotype analysis, allele-specific expression assays, RNA-seq in primary human CD4+ T cells, IL-2 secretion assays, splice-form quantification","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — allele-specific expression and functional IL-2 readout in primary cells; single study","pmids":["29491471"],"is_preprint":false},{"year":2019,"finding":"UBASH3A regulates TCR-CD3 complex synthesis and turnover: modulation of UBASH3A levels in unstimulated Jurkat cells alters total cellular CD3 chain amounts and cell-surface TCR-CD3 levels (but not CD28 levels). Upon TCR engagement, UBASH3A enhances downmodulation of surface TCR-CD3. Mass spectrometry and protein-protein interaction studies reveal novel associations between UBASH3A and components of ER-associated protein degradation (ERAD), cell motility, endocytosis, and endocytic recycling pathways. The SH3 domain of UBASH3A mediates binding to CBL-B, an E3 ubiquitin ligase that negatively regulates CD28-mediated signaling.","method":"UBASH3A modulation (overexpression/knockdown) in Jurkat cells, flow cytometry for surface TCR-CD3 and CD28, mass spectrometry interactome, co-immunoprecipitation, SH3 domain binding assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (flow cytometry, MS interactome, Co-IP, domain mapping) in single comprehensive study","pmids":["31659016"],"is_preprint":false},{"year":2020,"finding":"UBASH3A deficiency in NOD mice accelerates type 1 diabetes development in both sexes, is associated with increased β-cell autoreactive T cells in spleen and pancreatic lymph nodes, and promotes salivary gland inflammation in females. Adoptive transfer of UBASH3A-deficient splenic T cells into NOD.Rag1-/- mice was sufficient to promote T1D development, establishing that UBASH3A's protective effect is T cell-intrinsic.","method":"Zinc-finger nuclease-mediated knockout in NOD mice, diabetes incidence monitoring, insulitis scoring, flow cytometry for autoreactive T cells, adoptive transfer experiments","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — clean KO with adoptive transfer establishing T cell-intrinsic mechanism, multiple phenotypic readouts","pmids":["32694640"],"is_preprint":false},{"year":2022,"finding":"In rheumatoid arthritis CD4+ T cells, UBASH3A transcription is suppressed via epigenetic dysregulation of a super-enhancer: BACH2 (a silencing transcription factor) accumulates at UBASH3A loci while MED1/BRD4 (SE-defining factors) are reduced. Knockdown of enhancer RNAs (eRNA_1, eRNA_3) reduces UBASH3A mRNA. UBASH3A overexpression in RA patient CD4+ T cells significantly inhibits TCR-stimulated IL-6 production.","method":"ChIP for BACH2, MED1, BRD4 at UBASH3A loci, locked nucleic acid-mediated eRNA knockdown, RT-PCR, western blotting, UBASH3A overexpression in CD4+ T cells, cytometric bead array for IL-6","journal":"Inflammation and regeneration","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus functional overexpression with cytokine readout; single lab in patient samples","pmids":["36324153"],"is_preprint":false},{"year":2023,"finding":"UBASH3A physically interacts with PTPN22 in T cells via its SH3 domain, as demonstrated by co-immunoprecipitation. This interaction is not altered by the T1D risk coding variant rs2476601 in PTPN22. RNA-seq analysis of T1D cases shows that UBASH3A and PTPN22 transcript levels have a cooperative effect on IL-2 expression in primary CD8+ T cells, and the two T1D risk variants rs11203203 (UBASH3A) and rs2476601 (PTPN22) interact statistically to jointly affect T1D risk.","method":"Co-immunoprecipitation in T cells, SH3 domain binding assays, RNA-seq analysis of primary CD8+ T cells, genetic interaction analysis","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP plus RNA-seq functional analysis and genetic interaction; single lab","pmids":["37240014"],"is_preprint":false},{"year":2024,"finding":"FLI1 indirectly inhibits UBASH3A transcription via GATA2, thereby promoting erythroleukemia cell growth. UBASH3A knockdown in erythroleukemic cells increased proliferation, associated with dramatic induction of HSP70 gene HSPA1B; knockdown of HSPA1B accelerated leukemic cell proliferation, suggesting UBASH3A acts as a tumor suppressor in erythroleukemia partly by activating HSPA1B expression. Overexpression of UBASH3A across cancers is associated with good prognosis.","method":"ChIP analysis and luciferase assays for UBASH3A promoter, lentivirus-shRNA knockdown, RNA-seq, MTT proliferation assays, flow cytometry for apoptosis","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2-3 — promoter ChIP, functional KD with defined proliferation phenotype and mechanistic link to HSPA1B; single lab","pmids":["38461240"],"is_preprint":false},{"year":2021,"finding":"Germline knockout of Ubash3a in LEW.1W rats (which carry RT1B/Du MHC but are normally T1D-resistant) renders these rats relatively susceptible to autoimmune diabetes, demonstrating that UBASH3A provides a critical immunoregulatory checkpoint downstream of the T cell receptor that protects against autoimmunity even in the context of a susceptible MHC haplotype.","method":"Germline Ubash3a knockout in LEW.1W rats, diabetes incidence monitoring, Tcrb-V13S1A1 knockout comparison, in silico structural modeling of TCR-MHC interaction","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO in defined genetic background with diabetes phenotype; functional epistasis with TCR gene","pmids":["34205929"],"is_preprint":false}],"current_model":"UBASH3A (TULA/STS-2) is a lymphoid-enriched multi-domain adaptor/phosphatase that negatively regulates T cell activation through at least two distinct mechanisms: (1) its SH3 domain binds c-Cbl, CBL-B, PTPN22, dynamin, and non-degradative polyubiquitin chains/TAK1/NEMO to suppress NF-κB/IKK signaling, inhibit dynamin-dependent endocytosis, and modulate TCR-CD3 complex synthesis and turnover; (2) its PGM/2H-phosphatase domain has weak acid-dependent phosphatase activity (with His366 as the nucleophilic residue) that contributes modestly to ZAP-70 dephosphorylation in cooperation with the more active paralog UBASH3A/STS-1; additionally, UBASH3A promotes caspase-independent T cell apoptosis via interaction with AIF, undergoes UBA domain-dependent E3-independent monoubiquitination that limits its own ubiquitin-binding activity, and its UBA domain recruits it to HIV-1 assembly sites to inhibit viral budding."},"narrative":{"teleology":[{"year":2001,"claim":"Identification of UBASH3A as a novel lymphoid-restricted gene with a unique SH3–UBA–PGM domain architecture established the molecular foundation for its study as a potential immune signaling regulator.","evidence":"cDNA cloning, domain analysis, and tissue-restricted RT-PCR expression profiling","pmids":["11281453"],"confidence":"High","gaps":["No function assigned; domain activities unknown","Expression at protein level in lymphocyte subsets not confirmed"]},{"year":2004,"claim":"Genetic ablation of Sts-1 and Sts-2 in mice revealed that the two paralogs cooperate to negatively regulate TCR signaling, with double-knockout T cells showing hyperphosphorylated ZAP-70, increased cytokine production, and susceptibility to autoimmunity, establishing the core physiological role of the family.","evidence":"Double-knockout mouse T cells with phospho-ZAP-70 immunoblotting, cytokine assays, and EAE autoimmune model","pmids":["14738763"],"confidence":"High","gaps":["Individual contributions of Sts-1 vs Sts-2 not separated in the double KO","Mechanism of ZAP-70 regulation (direct dephosphorylation vs adaptor function) unresolved"]},{"year":2004,"claim":"Biochemical dissection showed that UBASH3A's SH3 domain binds c-Cbl and its UBA domain binds monoubiquitin, and that UBASH3A inhibits Cbl-mediated receptor downregulation and dynamin-dependent endocytosis, defining two key molecular interaction modes.","evidence":"Co-IP, mass spectrometry, EGFR trafficking assays, and endocytosis assays with multiple cargo types including dynamin rescue","pmids":["15107835","15159412","17382318"],"confidence":"High","gaps":["Physiological significance of endocytosis inhibition in lymphocytes not demonstrated","Relative importance of Cbl-binding versus dynamin-sequestration in T cell context unclear"]},{"year":2006,"claim":"Discovery that UBASH3A undergoes E3-independent monoubiquitination—with its own UBA domain directly cooperating with Ub-charged E2 enzymes—revealed a self-regulatory switch: monoubiquitinated UBASH3A loses the ability to bind ubiquitinated targets in trans, tuning its adaptor activity.","evidence":"In vitro E3-independent ubiquitination reconstitution, FRET, siRNA, ubiquitin fusion constructs, and EGFR trafficking assays","pmids":["16429130","17588522"],"confidence":"High","gaps":["Identity of E2 enzyme(s) responsible in T cells not defined","Dynamics of monoubiquitination/deubiquitination cycle in vivo unknown"]},{"year":2007,"claim":"Identification of AIF as a UBASH3A-interacting protein and demonstration that UBASH3A promotes caspase-independent apoptosis via AIF revealed a pro-apoptotic function distinct from its TCR-signaling role, while interaction with ABCE-1 and UBA-dependent inhibition of HIV-1 budding uncovered an antiviral function.","evidence":"Mass spectrometry interaction screens, AIF siRNA rescue of apoptosis, HIV-1 production assays with UBA domain mutants","pmids":["17709377","18006034"],"confidence":"High","gaps":["Physiological relevance of AIF-mediated apoptosis in T cell homeostasis not confirmed in vivo","Anti-HIV activity studied only in overexpression systems"]},{"year":2009,"claim":"Crystal structures of the UBASH3A PGM domain in apo, substrate-bound, phospho-intermediate, and transition-state forms established that His366 is the catalytic nucleophile and identified five non-conserved residues (Gln372, Ala446, Glu481, Ser552, Ser582) whose divergence from UBASH3B explains the dramatically lower phosphatase activity of UBASH3A.","evidence":"X-ray crystallography of multiple catalytic intermediates, site-directed mutagenesis restoring activity, pH-rate profiling","pmids":["19196006","19627098"],"confidence":"High","gaps":["Physiological substrate identity for UBASH3A phosphatase domain remains uncertain","Whether the weak phosphatase activity is biologically meaningful independent of the adaptor functions is unknown"]},{"year":2011,"claim":"Direct measurement confirmed that UBASH3A possesses weak but detectable phosphatase activity toward ZAP-70, and combinatorial peptide library screening showed no activity against a broad phosphotyrosyl panel, resolving the long-standing question of whether UBASH3A functions primarily as a phosphatase or as an adaptor.","evidence":"Combinatorial phosphopeptide library screen (negative result), T cell phospho-ZAP-70 assays, mutagenesis of specificity determinants","pmids":["20670933","21393235"],"confidence":"High","gaps":["Whether UBASH3A contributes to ZAP-70 dephosphorylation in vivo through direct activity or by recruiting UBASH3B/Nrdp1 remains debated"]},{"year":2015,"claim":"Discovery that Nrdp1 E3 ligase mediates K33-linked polyubiquitination of ZAP-70 and promotes its dephosphorylation by both Sts-1 and Sts-2 provided a molecular link between ubiquitin signaling and phosphatase-mediated TCR signal termination.","evidence":"K33 polyubiquitination assays, co-IP of Nrdp1/ZAP-70/Sts proteins, Nrdp1 knockout mice, T cell activation assays","pmids":["26390156"],"confidence":"High","gaps":["Whether UBASH3A's UBA domain directly recognizes K33-linked chains on ZAP-70 is not shown","Relative contribution of UBASH3A vs UBASH3B in Nrdp1-dependent dephosphorylation not quantified"]},{"year":2017,"claim":"Identification of UBASH3A as a suppressor of NF-κB/IKK signaling through novel interactions with non-degradative polyubiquitin chains, TAK1, and NEMO, combined with the finding that T1D risk alleles increase UBASH3A expression and reduce IL-2 production, established a distinct signaling axis beyond ZAP-70 dephosphorylation.","evidence":"siRNA/overexpression in primary human CD4+ T cells, IKK activity assays, co-IP with TAK1/NEMO/polyubiquitin, allele-specific expression","pmids":["28607106"],"confidence":"High","gaps":["Whether TAK1/NEMO interaction is direct or ubiquitin-mediated is not fully resolved","Structural basis of SH3 domain recognition of TAK1/NEMO unknown"]},{"year":2019,"claim":"Demonstration that UBASH3A controls steady-state TCR-CD3 complex levels and surface turnover, and identification of CBL-B and ERAD pathway components as interactors, expanded the functional model beyond signal transduction to receptor homeostasis.","evidence":"Flow cytometry for surface TCR-CD3 upon UBASH3A modulation, mass spectrometry interactome, co-IP of CBL-B via SH3 domain","pmids":["31659016"],"confidence":"High","gaps":["Whether UBASH3A promotes TCR-CD3 degradation through ERAD or endolysosomal pathways is unclear","Interactome not validated for all hits beyond CBL-B"]},{"year":2020,"claim":"UBASH3A knockout in NOD mice and LEW.1W rats accelerated autoimmune diabetes with increased β-cell autoreactive T cells, and adoptive transfer demonstrated a T cell-intrinsic protective mechanism, providing in vivo genetic proof that UBASH3A is a causal checkpoint gene for type 1 diabetes.","evidence":"Zinc-finger nuclease KO in NOD mice, germline KO in LEW.1W rats, diabetes incidence, insulitis scoring, adoptive transfer into Rag1−/− hosts","pmids":["32694640","34205929"],"confidence":"High","gaps":["Which UBASH3A-dependent pathway (NF-κB suppression, TCR-CD3 turnover, ZAP-70 dephosphorylation, or apoptosis) is most critical for T1D protection is unresolved","Human validation of knockout phenotype not available"]},{"year":2023,"claim":"Physical interaction of UBASH3A with PTPN22 via the SH3 domain and cooperative effects of their T1D risk variants on IL-2 expression revealed functional epistasis between two major T1D susceptibility genes at the protein level.","evidence":"Co-IP in T cells, SH3 domain binding assays, RNA-seq of primary CD8+ T cells, genetic interaction analysis","pmids":["37240014"],"confidence":"Medium","gaps":["Functional consequence of UBASH3A–PTPN22 interaction on phosphatase activity or substrate access not defined","Reciprocal co-IP not shown","Whether interaction occurs at the immunological synapse is unknown"]},{"year":2024,"claim":"Identification of UBASH3A as a tumor suppressor in erythroleukemia, acting downstream of FLI1/GATA2 to activate HSPA1B and suppress proliferation, extended UBASH3A's functional repertoire beyond lymphocyte regulation.","evidence":"ChIP and luciferase reporter for UBASH3A promoter, shRNA knockdown, RNA-seq, proliferation assays in erythroleukemic cells","pmids":["38461240"],"confidence":"Medium","gaps":["Mechanism by which UBASH3A activates HSPA1B transcription is unknown","Tumor-suppressive role not validated in vivo","Whether this function involves the same domains as immune regulation is unstudied"]},{"year":null,"claim":"The relative contributions of UBASH3A's adaptor functions (NF-κB suppression, TCR-CD3 turnover, endocytosis inhibition) versus its weak phosphatase activity to T cell homeostasis and autoimmune disease protection remain to be dissected in vivo with domain-specific mutants.","evidence":"","pmids":[],"confidence":"Low","gaps":["No domain-specific knock-in models exist to separate adaptor from phosphatase function in vivo","No structural model of full-length UBASH3A or its multi-domain complexes","Therapeutic potential of modulating UBASH3A expression or activity in autoimmunity is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[11,12,14]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,3,16,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,16,20]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,3,19]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,19]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,15,16,20,22]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,16,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[20,24]}],"complexes":[],"partners":["CBL","CBLB","PTPN22","DNM2","ZAP70","TAK1","NEMO","AIFM1"],"other_free_text":[]},"mechanistic_narrative":"UBASH3A (TULA/STS-2) is a lymphoid-enriched multi-domain adaptor protein that functions as a negative regulator of T cell receptor signaling and immune activation. Its SH3 domain mediates interactions with c-Cbl, CBL-B, PTPN22, dynamin, and NF-κB pathway components (TAK1, NEMO, non-degradative polyubiquitin chains), through which UBASH3A suppresses IKK/NF-κB activation, inhibits dynamin-dependent endocytosis, modulates TCR-CD3 complex synthesis and surface turnover, and cooperates with PTPN22 to set the TCR activation threshold [PMID:28607106, PMID:17382318, PMID:31659016, PMID:37240014]. Its PGM/2H-phosphatase domain possesses weak, acid-dependent phosphatase activity (His366 as nucleophilic residue) that contributes modestly to ZAP-70 dephosphorylation—substantially less than its paralog UBASH3B/STS-1—while its UBA domain undergoes E3-independent monoubiquitination that limits its own ubiquitin-binding capacity and regulates receptor trafficking [PMID:19196006, PMID:19627098, PMID:21393235, PMID:17588522]. Loss of UBASH3A in NOD mice and LEW.1W rats accelerates autoimmune diabetes development through a T cell-intrinsic mechanism, and type 1 diabetes risk alleles increase UBASH3A expression in stimulated CD4+ T cells, establishing UBASH3A as a causal immunoregulatory checkpoint gene for T1D [PMID:32694640, PMID:34205929, PMID:28607106]."},"prefetch_data":{"uniprot":{"accession":"P57075","full_name":"Ubiquitin-associated and SH3 domain-containing protein A","aliases":["Cbl-interacting protein 4","CLIP4","Suppressor of T-cell receptor signaling 2","STS-2","T-cell ubiquitin ligand 1","TULA-1"],"length_aa":661,"mass_kda":74.1,"function":"Interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. Promotes accumulation of activated target receptors, such as T-cell receptors, EGFR and PDGFRB, on the cell surface. Exhibits negligible protein tyrosine phosphatase activity at neutral pH. May act as a dominant-negative regulator of UBASH3B-dependent dephosphorylation. May inhibit dynamin-dependent endocytic pathways by functionally sequestering dynamin via its SH3 domain","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P57075/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/UBASH3A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CLASP1","stoichiometry":0.2},{"gene":"CLASP2","stoichiometry":0.2},{"gene":"PRKAA1","stoichiometry":0.2},{"gene":"TUBB4B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/UBASH3A","total_profiled":1310},"omim":[{"mim_id":"609201","title":"UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN B; UBASH3B","url":"https://www.omim.org/entry/609201"},{"mim_id":"605736","title":"UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN A; UBASH3A","url":"https://www.omim.org/entry/605736"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear speckles","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":17.6}],"url":"https://www.proteinatlas.org/search/UBASH3A"},"hgnc":{"alias_symbol":["STS-2","TULA","CLIP4"],"prev_symbol":[]},"alphafold":{"accession":"P57075","domains":[{"cath_id":"3.90.1140.10","chopping":"72-186_224-274","consensus_level":"medium","plddt":90.9233,"start":72,"end":274},{"cath_id":"2.30.30.40","chopping":"278-345","consensus_level":"medium","plddt":91.5263,"start":278,"end":345},{"cath_id":"3.40.50.1240","chopping":"398-407_455-638","consensus_level":"high","plddt":91.9715,"start":398,"end":638}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P57075","model_url":"https://alphafold.ebi.ac.uk/files/AF-P57075-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P57075-F1-predicted_aligned_error_v6.png","plddt_mean":82.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=UBASH3A","jax_strain_url":"https://www.jax.org/strain/search?query=UBASH3A"},"sequence":{"accession":"P57075","fasta_url":"https://rest.uniprot.org/uniprotkb/P57075.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P57075/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P57075"}},"corpus_meta":[{"pmid":"7966573","id":"PMC_7966573","title":"Tula virus: a newly detected hantavirus carried by European common voles.","date":"1994","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7966573","citation_count":176,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14738763","id":"PMC_14738763","title":"Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2.","date":"2004","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/14738763","citation_count":152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15159412","id":"PMC_15159412","title":"Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15159412","citation_count":119,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17705180","id":"PMC_17705180","title":"Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter.","date":"2007","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/17705180","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9000098","id":"PMC_9000098","title":"Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae.","date":"1996","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/9000098","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20219926","id":"PMC_20219926","title":"Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses.","date":"2010","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20219926","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9847372","id":"PMC_9847372","title":"Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia.","date":"1999","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9847372","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8862399","id":"PMC_8862399","title":"Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein.","date":"1996","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/8862399","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8837887","id":"PMC_8837887","title":"Genetic variation in Tula hantaviruses: sequence analysis of the S and M segments of strains from Central Europe.","date":"1995","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/8837887","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15107835","id":"PMC_15107835","title":"TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15107835","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21393235","id":"PMC_21393235","title":"Sts-2 is a phosphatase that negatively regulates zeta-associated protein (ZAP)-70 and T cell receptor signaling pathways.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21393235","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20585042","id":"PMC_20585042","title":"A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20585042","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9334930","id":"PMC_9334930","title":"Puumala virus and two genetic variants of Tula virus are present in Austrian rodents.","date":"1997","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/9334930","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15708603","id":"PMC_15708603","title":"Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells.","date":"2005","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/15708603","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28607106","id":"PMC_28607106","title":"UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-κB Signaling.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/28607106","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18189269","id":"PMC_18189269","title":"TULA proteins regulate activity of the protein tyrosine kinase Syk.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18189269","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11281453","id":"PMC_11281453","title":"Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains.","date":"2001","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11281453","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20670933","id":"PMC_20670933","title":"Determination of the substrate specificity of protein-tyrosine phosphatase TULA-2 and identification of Syk as a TULA-2 substrate.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20670933","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12606074","id":"PMC_12606074","title":"Non-covalent interaction between nucleocapsid protein of Tula hantavirus and small ubiquitin-related modifier-1, SUMO-1.","date":"2003","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/12606074","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31659016","id":"PMC_31659016","title":"UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31659016","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22225425","id":"PMC_22225425","title":"Tula virus infections in the Eurasian water vole in Central Europe.","date":"2012","source":"Vector borne and zoonotic diseases (Larchmont, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22225425","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24209605","id":"PMC_24209605","title":"Tula hantavirus infection in immunocompromised host, Czech Republic.","date":"2013","source":"Emerging infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24209605","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15483239","id":"PMC_15483239","title":"Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation.","date":"2004","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/15483239","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11889055","id":"PMC_11889055","title":"Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11889055","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8896239","id":"PMC_8896239","title":"Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein.","date":"1996","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/8896239","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26831932","id":"PMC_26831932","title":"High genetic structuring of Tula hantavirus.","date":"2016","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/26831932","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22689384","id":"PMC_22689384","title":"TULA-family proteins: a new class of cellular regulators.","date":"2013","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22689384","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22267732","id":"PMC_22267732","title":"Once phosphorylated, tyrosines in carboxyl terminus of protein-tyrosine kinase Syk interact with signaling proteins, including TULA-2, a negative regulator of mast cell degranulation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22267732","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14512541","id":"PMC_14512541","title":"Mapping of the regions involved in homotypic interactions of Tula hantavirus N protein.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/14512541","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17382318","id":"PMC_17382318","title":"The Cbl-interacting protein TULA inhibits dynamin-dependent endocytosis.","date":"2007","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17382318","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21367904","id":"PMC_21367904","title":"The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction.","date":"2011","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/21367904","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28418867","id":"PMC_28418867","title":"Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28418867","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23149425","id":"PMC_23149425","title":"TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function.","date":"2012","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/23149425","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23565265","id":"PMC_23565265","title":"Evidence of new risk genetic factor to systemic lupus erythematosus: the UBASH3A gene.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23565265","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15105534","id":"PMC_15105534","title":"Tula hantavirus L protein is a 250 kDa perinuclear membrane-associated protein.","date":"2004","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/15105534","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19196006","id":"PMC_19196006","title":"Structural and functional characterization of the 2H-phosphatase domain of Sts-2 reveals an acid-dependent phosphatase activity.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19196006","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12044299","id":"PMC_12044299","title":"Identification of Tula hantavirus in Pitymys subterraneus captured in the Cacak region of Serbia-Yugoslavia.","date":"2002","source":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12044299","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18190677","id":"PMC_18190677","title":"Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF.","date":"2008","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/18190677","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26691901","id":"PMC_26691901","title":"Tula hantavirus infection in a hospitalised patient, France, June 2015.","date":"2015","source":"Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/26691901","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8971044","id":"PMC_8971044","title":"Quasispecies in wild-type tula hantavirus populations.","date":"1996","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/8971044","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9820136","id":"PMC_9820136","title":"Completion of the Tula hantavirus genome sequence: properties of the L segment and heterogeneity found in the 3' termini of S and L genome RNAs.","date":"1998","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/9820136","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27609517","id":"PMC_27609517","title":"TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)346, a Regulatory Site of Syk.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27609517","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18344182","id":"PMC_18344182","title":"Multidomain STS/TULA proteins are novel cellular regulators.","date":"2008","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/18344182","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25047644","id":"PMC_25047644","title":"Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo.","date":"2014","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25047644","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29901187","id":"PMC_29901187","title":"A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29901187","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29491471","id":"PMC_29491471","title":"Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes.","date":"2018","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/29491471","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27283491","id":"PMC_27283491","title":"FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27283491","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18006034","id":"PMC_18006034","title":"TULA proteins bind to ABCE-1, a host factor of HIV-1 assembly, and inhibit HIV-1 biogenesis in a UBA-dependent fashion.","date":"2007","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/18006034","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27765766","id":"PMC_27765766","title":"TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.","date":"2016","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27765766","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19956987","id":"PMC_19956987","title":"Tula hantavirus NSs protein accumulates in the perinuclear area in infected and transfected cells.","date":"2009","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19956987","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31639493","id":"PMC_31639493","title":"TULA proteins as signaling regulators.","date":"2019","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/31639493","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24008094","id":"PMC_24008094","title":"Evidence of recombination in Tula virus strains from Serbia.","date":"2013","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24008094","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30076707","id":"PMC_30076707","title":"TULA-family proteins: Jacks of many trades and then some.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30076707","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32694640","id":"PMC_32694640","title":"UBASH3A deficiency accelerates type 1 diabetes development and enhances salivary gland inflammation in NOD mice.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32694640","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19627098","id":"PMC_19627098","title":"Structures of the phosphorylated and VO(3)-bound 2H-phosphatase domain of Sts-2.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19627098","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25843625","id":"PMC_25843625","title":"Association of UBASH3A gene polymorphisms and systemic lupus erythematosus in a Chinese population.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25843625","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19440462","id":"PMC_19440462","title":"New Genetic Lineage of Tula Hantavirus in Microtus arvalis obscurus in Eastern Kazakhstan.","date":"2008","source":"The open virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/19440462","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18836679","id":"PMC_18836679","title":"First detection of Tula hantaviruses in Microtus arvalis voles in Hungary.","date":"2008","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/18836679","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28747736","id":"PMC_28747736","title":"Association of UBASH3A gene polymorphism and atopic dermatitis in the Chinese Han population.","date":"2017","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/28747736","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36324153","id":"PMC_36324153","title":"IL-6 production through repression of UBASH3A gene via epigenetic dysregulation of super-enhancer in CD4+ T cells in rheumatoid arthritis.","date":"2022","source":"Inflammation and regeneration","url":"https://pubmed.ncbi.nlm.nih.gov/36324153","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33201836","id":"PMC_33201836","title":"miR-25-3p promotes endothelial cell angiogenesis in aging mice via TULA-2/SYK/VEGFR-2 downregulation.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33201836","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19675185","id":"PMC_19675185","title":"Degradation and aggresome formation of the Gn tail of the apathogenic Tula hantavirus.","date":"2009","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/19675185","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28759203","id":"PMC_28759203","title":"Structural and Functional Characterization of the Histidine Phosphatase Domains of Human Sts-1 and Sts-2.","date":"2017","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28759203","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31249969","id":"PMC_31249969","title":"TULA-2 Deficiency Enhances Platelet Functional Responses to CLEC-2 Agonists.","date":"2018","source":"TH open : companion journal to thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/31249969","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34502088","id":"PMC_34502088","title":"CRKL, AIFM3, AIF, BCL2, and UBASH3A during Human Kidney Development.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34502088","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32605035","id":"PMC_32605035","title":"The RNA Replication Site of Tula Orthohantavirus Resides within a Remodelled Golgi Network.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32605035","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8883363","id":"PMC_8883363","title":"Unique and conserved features of Tula hantavirus M gene encoding envelope glycoproteins G1 and G2.","date":"1996","source":"Virus genes","url":"https://pubmed.ncbi.nlm.nih.gov/8883363","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28972439","id":"PMC_28972439","title":"Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice.","date":"2017","source":"Modern rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/28972439","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25433134","id":"PMC_25433134","title":"Adler hantavirus, a new genetic variant of Tula virus identified in Major's pine voles (Microtus majori) sampled in southern European Russia.","date":"2014","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25433134","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31540120","id":"PMC_31540120","title":"Puumala and Tula Virus Differ in Replication Kinetics and Innate Immune Stimulation in Human Endothelial Cells and Macrophages.","date":"2019","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/31540120","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33968748","id":"PMC_33968748","title":"Feasibility of Methylated CLIP4 in Stool for Early Detection of Colorectal Cancer: A Training Study in Chinese Population.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33968748","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30465911","id":"PMC_30465911","title":"A novel genetic lineage of Tula orthohantavirus in Altai voles (Microtus obscurus) from Turkey.","date":"2018","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/30465911","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31446137","id":"PMC_31446137","title":"Identification and characterization of a novel subtype of Tula virus in Microtus arvalis obscurus voles sampled from Xinjiang, China.","date":"2019","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31446137","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38461240","id":"PMC_38461240","title":"FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.","date":"2024","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38461240","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37298079","id":"PMC_37298079","title":"TULA Proteins in Men, Mice, Hens, and Lice: Welcome to the Family.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37298079","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34965217","id":"PMC_34965217","title":"Coupling of serum CK20 and hyper-methylated CLIP4 as promising biomarker for colorectal cancer diagnosis: from bioinformatics screening to clinical validation.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34965217","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29262569","id":"PMC_29262569","title":"Evaluation of the association of UBASH3A and SYNGR1 with rheumatoid arthritis and disease activity and severity in Han Chinese.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29262569","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23484131","id":"PMC_23484131","title":"Air pollutant characterization in Tula industrial corridor, Central Mexico, during the MILAGRO study.","date":"2013","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/23484131","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37240014","id":"PMC_37240014","title":"UBASH3A Interacts with PTPN22 to Regulate IL2 Expression and Risk for Type 1 Diabetes.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37240014","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39121973","id":"PMC_39121973","title":"miR-135b-5p promotes gastric carcinogenesis by targeting CLIP4-mediated JAK2/STAT3 signal pathway.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/39121973","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35212154","id":"PMC_35212154","title":"Response to ALK-TKIs in a lung adenocarcinoma patient harboring dual DCTN1-ALK and ALK-CLIP4 rearrangements.","date":"2022","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35212154","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20116854","id":"PMC_20116854","title":"Different cross-reactivity of human and rodent sera to Tula virus and Puumala virus.","date":"2010","source":"Comparative immunology, microbiology and infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20116854","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34205929","id":"PMC_34205929","title":"T Cell Receptor Genotype and Ubash3a Determine Susceptibility to Rat Autoimmune Diabetes.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34205929","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17425435","id":"PMC_17425435","title":"Chemokine production predominates in human monocytes infected with Tula virus.","date":"2007","source":"Viral immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17425435","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34208398","id":"PMC_34208398","title":"Spatial and Temporal Dynamics and Molecular Evolution of Tula orthohantavirus in German Vole Populations.","date":"2021","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/34208398","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33575272","id":"PMC_33575272","title":"CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/33575272","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15725355","id":"PMC_15725355","title":"Recombinant Tula hantavirus shows reduced fitness but is able to survive in the presence of a parental virus: analysis of consecutive passages in a cell culture.","date":"2005","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/15725355","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39558087","id":"PMC_39558087","title":"Roles of TULA-family proteins in T cells and autoimmune diseases.","date":"2024","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/39558087","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25211447","id":"PMC_25211447","title":"Lack of association between polymorphisms in the UBASH3A gene and autoimmune thyroid disease: a case control study.","date":"2014","source":"Arquivos brasileiros de endocrinologia e metabologia","url":"https://pubmed.ncbi.nlm.nih.gov/25211447","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35746729","id":"PMC_35746729","title":"Molecular Characterisation and Phylogeny of Tula Virus in Kazakhstan.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/35746729","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31268416","id":"PMC_31268416","title":"Tula orthohantavirus nucleocapsid protein is cleaved in infected cells and may sequester activated caspase-3 during persistent infection to suppress apoptosis.","date":"2019","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/31268416","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34320644","id":"PMC_34320644","title":"FREQUENT LEPTOSPIRA SPP. DETECTION BUT ABSENCE OF TULA ORTHOHANTAVIRUS IN MICROTUS SPP. VOLES, NORTHWESTERN SPAIN.","date":"2021","source":"Journal of wildlife diseases","url":"https://pubmed.ncbi.nlm.nih.gov/34320644","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24587276","id":"PMC_24587276","title":"Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24587276","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36499237","id":"PMC_36499237","title":"TULA-Family Regulators of Platelet Activation.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36499237","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37298164","id":"PMC_37298164","title":"STS-1 and STS-2, Multi-Enzyme Proteins Equipped to Mediate Protein-Protein Interactions.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37298164","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31200661","id":"PMC_31200661","title":"Molecular evidence of Tula virus in Microtus obscurus in the region of Yili, Xinjiang, China.","date":"2019","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31200661","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38361825","id":"PMC_38361825","title":"Genome-wide support for incipient Tula hantavirus species within a single rodent host lineage.","date":"2024","source":"Virus evolution","url":"https://pubmed.ncbi.nlm.nih.gov/38361825","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39920578","id":"PMC_39920578","title":"Endoplasmic reticulum stress-related CLIP4 plays a procarcinogenic role in hepatocellular carcinoma: an integrated analysis.","date":"2025","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39920578","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40707988","id":"PMC_40707988","title":"Exploring UBASH3A: from immune regulation to autoimmune diseases.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40707988","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38674019","id":"PMC_38674019","title":"Role of Tula-Family Proteins in Cell Signaling and Activation: Advances and Challenges.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38674019","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24390342","id":"PMC_24390342","title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/24390342","citation_count":1778,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19430480","id":"PMC_19430480","title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19430480","citation_count":1382,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20453842","id":"PMC_20453842","title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20453842","citation_count":1018,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18854154","id":"PMC_18854154","title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18854154","citation_count":787,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19073967","id":"PMC_19073967","title":"Shared and distinct genetic variants in type 1 diabetes and celiac disease.","date":"2008","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19073967","citation_count":566,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20410501","id":"PMC_20410501","title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.","date":"2010","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20410501","citation_count":304,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21383967","id":"PMC_21383967","title":"Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21383967","citation_count":297,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16429130","id":"PMC_16429130","title":"Regulation of ubiquitin-binding proteins by monoubiquitination.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16429130","citation_count":271,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21829393","id":"PMC_21829393","title":"Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21829393","citation_count":215,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18570454","id":"PMC_18570454","title":"Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry.","date":"2008","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/18570454","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19380743","id":"PMC_19380743","title":"Charting the molecular network of the drug target Bcr-Abl.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19380743","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17588522","id":"PMC_17588522","title":"E3-independent monoubiquitination of ubiquitin-binding proteins.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17588522","citation_count":128,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18840781","id":"PMC_18840781","title":"Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes.","date":"2008","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18840781","citation_count":121,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17599067","id":"PMC_17599067","title":"Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17599067","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14968112","id":"PMC_14968112","title":"Identification of NPM-ALK interacting proteins by tandem mass spectrometry.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14968112","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26390156","id":"PMC_26390156","title":"K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26390156","citation_count":82,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35256949","id":"PMC_35256949","title":"Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy.","date":"2021","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/35256949","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31515488","id":"PMC_31515488","title":"Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31515488","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"37071682","id":"PMC_37071682","title":"Cross-linking mass spectrometry discovers, evaluates, and corroborates structures and protein-protein interactions in the human cell.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37071682","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25075402","id":"PMC_25075402","title":"Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers.","date":"2013","source":"Pediatric diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25075402","citation_count":53,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17709377","id":"PMC_17709377","title":"T-cell ubiquitin ligand affects cell death through a functional interaction with apoptosis-inducing factor, a key factor of caspase-independent apoptosis.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17709377","citation_count":37,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17880946","id":"PMC_17880946","title":"Suppressor of T-cell receptor signalling 1 and 2 differentially regulate endocytosis and signalling of receptor tyrosine kinases.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17880946","citation_count":33,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46618,"output_tokens":5113,"usd":0.108274},"stage2":{"model":"claude-opus-4-6","input_tokens":8650,"output_tokens":3481,"usd":0.195412},"total_usd":0.686592,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":60091,"output_tokens":8898,"usd":0.156871},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":11033,"output_tokens":3821,"usd":0.226035}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Sts-1 (UBASH3B) and Sts-2 (UBASH3A) negatively regulate TCR signaling by suppressing ZAP-70 phosphorylation and activation; T cells from Sts-1/2 double-knockout mice are hyperresponsive to TCR stimulation with increased ZAP-70 phosphorylation, elevated cytokine production, and increased susceptibility to autoimmunity in a mouse model of multiple sclerosis.\",\n      \"method\": \"Double-knockout mouse model, T cell stimulation assays, phosphorylation analysis, cytokine measurement, EAE model\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple readouts in vivo and in vitro\",\n      \"pmids\": [\"14738763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"UBASH3A (TULA/STS-2) binds to c-Cbl via its SH3 domain, binds ubiquitin via its UBA domain, and inhibits c-Cbl-mediated downregulation of EGF receptor, leading to upregulation of ZAP-70 and NF-AT activity in Jurkat T cells; TULA promotes ubiquitylation and degradation of c-Cbl.\",\n      \"method\": \"Affinity chromatography, mass spectrometry, co-expression in 293T cells, functional assays in Jurkat cells\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — pulldown + functional co-expression assays, single lab\",\n      \"pmids\": [\"15107835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Sts-1 and Sts-2 (UBASH3A) contain SH3 domains that interact with Cbl, UBA domains that bind mono-ubiquitin and ubiquitinated EGFR, and PGM domains that mediate oligomerization; recruitment into activated EGFR complexes inhibits receptor internalization and endocytic vesicle formation, blocking receptor degradation and prolonging mitogenic signaling.\",\n      \"method\": \"Co-immunoprecipitation, domain-binding assays, endocytosis assays, fluorescence microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, domain dissection, multiple orthogonal functional assays\",\n      \"pmids\": [\"15159412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"UBASH3A (TULA) inhibits dynamin-dependent endocytosis (both clathrin-dependent and clathrin-independent) by functionally sequestering dynamin via its SH3 domain binding proline-rich sequences in dynamin; TULA and dynamin co-immunoprecipitate and colocalize intracellularly.\",\n      \"method\": \"Co-immunoprecipitation, endocytosis assays (transferrin, LDL, CD59, MHC-I, EGFR uptake), overexpression of dynamin rescue experiments, fluorescence microscopy\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, multiple functional readouts, domain-specific mechanism, rescue experiment\",\n      \"pmids\": [\"17382318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UBASH3A (TULA) has negligible phosphatase activity compared to TULA-2 (UBASH3B/STS-1); overexpressed TULA increases Syk tyrosine phosphorylation in cells, acting as a dominant-negative inhibitor of endogenous TULA-2-dependent dephosphorylation of Syk, suggesting TULA acts as a negative regulator of TULA-2 phosphatase activity.\",\n      \"method\": \"In vitro phosphatase assays, co-transfection overexpression assays, in vivo phosphorylation analysis of Syk\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/3 — in vitro phosphatase assays combined with cell-based overexpression, single lab\",\n      \"pmids\": [\"18189269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The crystal structure of the PGM/2H-phosphatase domain of Sts-2 (UBASH3A) was solved in apo, tungstate-bound, and phosphate-bound forms, revealing an active site with pH optimum at 5.0; non-conserved active site residues Gln372, Ala446, Glu481, Ser552, and Ser582 are responsible for the lower phosphatase activity of Sts-2 compared to Sts-1.\",\n      \"method\": \"X-ray crystallography, active site mutagenesis, enzyme kinetics\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis and kinetic validation\",\n      \"pmids\": [\"19196006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structures of the phosphorylated (His366-phosphorylated intermediate) and vanadate-bound (transition state analogue) forms of Sts-2 PGM domain were determined, revealing the nucleophilic histidine mechanism and a partially associative reaction mechanism for the phosphatase.\",\n      \"method\": \"X-ray crystallography of phosphorylated and VO3-bound enzyme forms\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural determination of catalytic intermediates with mechanistic interpretation\",\n      \"pmids\": [\"19627098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Systematic substrate specificity profiling using a combinatorial phosphotyrosyl peptide library showed that TULA-1 (UBASH3A) has no detectable phosphatase activity toward any phosphotyrosyl peptide substrates tested, while TULA-2 (UBASH3B) has clear substrate preferences including high activity toward Syk Tyr-323 and Tyr-352 sites.\",\n      \"method\": \"Combinatorial Tyr(P) peptide library screening, kinetic analysis of peptide substrates, Syk phosphorylation in TULA-2 knockout platelets\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic biochemical screening with kinetic validation and KO confirmation\",\n      \"pmids\": [\"20670933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Sts-2 (UBASH3A) regulates tyrosine phosphorylation levels on ZAP-70 in T cells; its PGM domain has weak but measurable phosphatase activity; residues Glu-481, Ser-552, and Ser-582 are specificity determinants — mutating these to their Sts-1 counterparts substantially increases Sts-2 phosphatase activity.\",\n      \"method\": \"In vitro phosphatase assays with new phosphorylated substrates, active site mutagenesis, T cell phosphorylation analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assays with mutagenesis and cell-based validation\",\n      \"pmids\": [\"21393235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UBASH3A attenuates NF-κB signaling downstream of TCR stimulation in human T cells by specifically suppressing activation of the IκB kinase (IKK) complex; UBASH3A interacts with non-degradative polyubiquitin chains, TAK1, and NEMO, suggesting ubiquitin-dependent regulation of NF-κB; T1D risk alleles at rs11203203 and rs80054410 increase UBASH3A expression, leading to inhibited NF-κB signaling and reduced IL-2 production.\",\n      \"method\": \"Co-immunoprecipitation (UBASH3A with TAK1, NEMO, polyubiquitin chains), siRNA knockdown, overexpression in primary human CD4+ T cells, NF-κB reporter assays, IL-2 measurement\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of novel interactions, multiple orthogonal functional readouts in primary human T cells\",\n      \"pmids\": [\"28607106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UBASH3A regulates TCR-CD3 complex synthesis and turnover: modulation of UBASH3A levels alters total cellular CD3 chain amounts and cell-surface TCR-CD3 complexes but not CD28; upon TCR engagement, UBASH3A enhances downmodulation of cell-surface TCR-CD3; the SH3 domain of UBASH3A mediates binding to CBL-B (an E3 ubiquitin ligase); UBASH3A associates with components of ER-associated protein degradation, endocytosis, and endocytic recycling pathways.\",\n      \"method\": \"Flow cytometry (surface TCR-CD3, CD28), mass spectrometry, protein-protein interaction studies, SH3 domain binding assays, siRNA/overexpression in Jurkat cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including MS interactome, flow cytometry, domain-specific binding, functional KD/OE\",\n      \"pmids\": [\"31659016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"UBASH3A (TULA) binds ABCE-1 (a host factor of HIV-1 assembly) and inhibits production of HIV-1 viral particles in a UBA domain-dependent manner; ABCE-1 recruits TULA to sites of HIV-1 assembly where TULA interferes with late steps of the HIV-1 life cycle.\",\n      \"method\": \"Mass spectrometry identification, Co-IP, UBA domain mutants, HIV-1 particle production assays\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — Co-IP and domain mutant functional assays, single lab\",\n      \"pmids\": [\"18006034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"UBASH3A encodes a 661-amino-acid protein containing SH3, UBA, and a novel phosphoglycerate mutase-like domain with a nuclear localization signal; expression is highest in spleen, peripheral blood leukocytes, and bone marrow; it is the first protein described containing both UBA and SH3 domains.\",\n      \"method\": \"cDNA cloning, domain analysis, RT-PCR expression profiling, genomic structure determination\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — initial gene characterization with domain identification, no direct functional assay\",\n      \"pmids\": [\"11281453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crystal structures of the histidine phosphatase domains of human Sts-1 (UBASH3B) and Sts-2 (UBASH3A) were determined; Sts-1HP has significantly higher phosphatase activity than Sts-2HP; PHPS1 (a SHP-1 inhibitor) inhibits Sts-1 with Ki = 1.05 μM; human Sts-1 has robust phosphatase activity against Zap-70 in a cell-based assay; Sts-1HP is a functional surrogate for full-length Sts-1.\",\n      \"method\": \"X-ray crystallography, steady-state kinetics, inhibitor testing, cell-based phosphatase assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with kinetic characterization and cell-based validation\",\n      \"pmids\": [\"28759203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The minor allele of rs1893592 in UBASH3A protects against T1D by reducing overall UBASH3A mRNA levels and increasing an alternatively spliced intron-9-retaining transcript that cannot produce full-length UBASH3A protein, resulting in increased IL-2 secretion upon TCR stimulation in primary CD4+ T cells.\",\n      \"method\": \"Haplotype analysis, RNA-seq, allele-specific expression analysis, IL-2 measurement in primary human CD4+ T cells\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional genomic analysis with allele-specific expression and cytokine readout in primary cells\",\n      \"pmids\": [\"29491471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"UBASH3A deficiency in NOD mice accelerates T1D development and enhances salivary gland inflammation; adoptive transfer of UBASH3A-deficient splenic T cells into NOD.Rag1-/- mice is sufficient to promote T1D, demonstrating that the UBASH3A effect is T cell-intrinsic.\",\n      \"method\": \"Zinc-finger nuclease knockout in NOD mice, insulitis scoring, diabetes incidence, flow cytometry of autoreactive T cells, adoptive transfer experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with adoptive transfer epistasis demonstrating T cell-intrinsic mechanism\",\n      \"pmids\": [\"32694640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UBASH3A physically interacts with PTPN22 in T cells via its SH3 domain; this interaction is not altered by the T1D risk variant rs2476601 in PTPN22; UBASH3A and PTPN22 transcript levels cooperatively affect IL-2 expression in human primary CD8+ T cells; rs11203203 in UBASH3A and rs2476601 in PTPN22 statistically interact in affecting T1D risk.\",\n      \"method\": \"Co-immunoprecipitation, domain-specific binding (SH3 domain), RNA-seq analysis, genetic association analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with domain specificity, supported by transcriptomic and genetic evidence\",\n      \"pmids\": [\"37240014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In rheumatoid arthritis CD4+ T cells, UBASH3A transcription is suppressed via epigenetic regulation of a super-enhancer by BACH2 accumulation and reduced MED1/BRD4 occupancy; reduced UBASH3A expression leads to excessive TCR signal activation and enhanced IL-6 production; overexpression of UBASH3A significantly inhibits IL-6 production upon TCR stimulation.\",\n      \"method\": \"ChIP, eRNA knockdown (locked nucleic acid), RT-PCR, western blotting, cytometric bead array, UBASH3A overexpression\",\n      \"journal\": \"Inflammation and regeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional overexpression with cytokine readout, single lab\",\n      \"pmids\": [\"36324153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TULA-family proteins (including UBASH3A) suppress T-cell-driven inflammatory responses in vivo; single KO of UBASH3A exacerbates TNBS-induced colitis in mice, with increased T-cell responses and altered ZAP-70 phosphorylation; the effect of UBASH3A single KO is distinct from but additive with TULA-2 single KO.\",\n      \"method\": \"TNBS-induced colitis mouse model, single and double KO comparison, flow cytometry, TCR-mediated signaling analysis\",\n      \"journal\": \"Immunology and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined in vivo inflammatory phenotype and signaling readout\",\n      \"pmids\": [\"25047644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FLI1 indirectly inhibits UBASH3A transcription via GATA2, thereby antagonizing leukemic growth; UBASH3A knockdown in erythroleukemic cells increases proliferation associated with induction of HSP70 (HSPA1B); UBASH3A acts as a tumor suppressor in erythroleukemia through activation of HSPA1B.\",\n      \"method\": \"Luciferase assays, ChIP, lentiviral shRNA knockdown, RNAseq, MTT assays, flow cytometry\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and functional KD with transcriptomic validation, single lab\",\n      \"pmids\": [\"38461240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"STS-2/UBASH3A knockout mice develop collagen-induced arthritis more frequently than wild-type mice; STS-2 KO CD4+ T cells show increased IL-2 production upon TCR stimulation, suggesting that STS-2 regulates autoimmune arthritis primarily through controlling IL-2 production in T cells.\",\n      \"method\": \"Collagen-induced arthritis model, intracellular cytokine staining, flow cytometry, in vitro TCR stimulation assays\",\n      \"journal\": \"Modern rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined in vivo and in vitro phenotype, single lab\",\n      \"pmids\": [\"28972439\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UBASH3A (TULA/STS-2) is a multidomain lymphoid adaptor/phosphatase protein that negatively regulates TCR signaling through at least two mechanisms: (1) acting as a weak protein tyrosine phosphatase (via its 2H-phosphatase/PGM domain with a catalytic nucleophilic histidine) to dephosphorylate ZAP-70 and suppress proximal TCR kinase activation, and (2) acting as an adaptor that interacts—via its SH3 domain—with CBL-B, PTPN22, dynamin, and ubiquitin chain-associated signaling components (TAK1, NEMO) to suppress the IKK/NF-κB pathway and regulate TCR-CD3 complex turnover and endocytosis, collectively setting the threshold for T cell activation and IL-2 production.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEEP papers.\n\n**Classification notes:**\n- Papers about Tula *virus* (hantavirus): EXCLUDE — symbol collision (TULV = Tula Virus, not UBASH3A)\n- Papers about CLIP4 (a different gene): EXCLUDE — alias collision\n- Papers about UBASH3A/TULA/STS-2/Sts-2 (the human protein): KEEP\n- Papers about TULA-2/STS-1/UBASH3B (the paralog): these describe the *paralog*, not UBASH3A itself — EXCLUDE unless they directly test UBASH3A function too\n- GWAS/association-only papers: not mechanistic — skip for discoveries but keep classification\n\n**KEEP papers (mechanistic findings about UBASH3A/TULA/STS-2):**\n- PMID:14738763 (Sts-1 and Sts-2 negative regulate TCR/ZAP-70) — KEEP (Sts-2 = UBASH3A)\n- PMID:15159412 (Sts-1 and Sts-2 bind Cbl, inhibit RTK endocytosis) — KEEP (Sts-2 = UBASH3A)\n- PMID:15107835 (TULA binds c-Cbl, ubiquitin) — KEEP\n- PMID:21393235 (Sts-2 phosphatase activity on ZAP-70) — KEEP\n- PMID:11281453 (UBASH3A gene isolation, domain characterization) — KEEP\n- PMID:28607106 (UBASH3A mediates NF-κB signaling risk for T1D) — KEEP\n- PMID:31659016 (UBASH3A regulates TCR-CD3 complexes) — KEEP\n- PMID:18189269 (TULA proteins regulate Syk activity) — KEEP (tests both; TULA=UBASH3A)\n- PMID:22689384 (TULA-family review with mechanistic data) — KEEP\n- PMID:17382318 (TULA inhibits dynamin-dependent endocytosis) — KEEP\n- PMID:48 (PMID:18006034, TULA binds ABCE-1, inhibits HIV-1) — KEEP\n- PMID:17709377 (TULA interacts with AIF, promotes apoptosis) — KEEP\n- PMID:19196006 (Sts-2 PGM domain crystal structure) — KEEP (Sts-2=UBASH3A)\n- PMID:19627098 (Sts-2 PGM phosphorylated/VO3-bound structures) — KEEP\n- PMID:28759203 (Human Sts-1 and Sts-2 HP domain structure/kinetics) — KEEP\n- PMID:38461240 (FLI1 regulates UBASH3A/B in erythroleukemia) — KEEP\n- PMID:37240014 (UBASH3A interacts with PTPN22) — KEEP\n- PMID:39558087 (TULA roles in T cells review with mechanistic detail) — KEEP\n- PMID:40707988 (UBASH3A review) — KEEP\n- PMID:29491471 (UBASH3A noncoding variants, mechanistic) — KEEP\n- PMID:32694640 (UBASH3A deficiency in NOD mice) — KEEP\n- PMID:36324153 (UBASH3A/IL-6 in RA via super-enhancer) — KEEP\n- PMID:34205929 (Ubash3a in rat diabetes) — KEEP\n- PMID:16429130 (monoubiquitination of Sts-2) — KEEP (Sts-2=UBASH3A)\n- PMID:17588522 (E3-independent monoubiquitination of UBD proteins including Sts-2) — KEEP\n- PMID:17880946 (Sts-1 vs Sts-2 differential endocytosis) — KEEP\n- PMID:26390156 (Nrdp1 K33-ub of Zap70, Sts-1/Sts-2 dephosphorylation) — KEEP\n- PMID:24587276 (Sts dKO and MHV68) — KEEP (Sts-2=UBASH3A, but focus is dKO)\n- PMID:25047644 (TULA-family in colitis model) — KEEP (tests TULA single KO)\n\n**EXCLUDE (Tula virus papers):** PMIDs 7966573, 17705180, 9000098, 20219926, 9847372, 8862399, 8837887, 15708603, 15483239, 11889055, 8896239, 26831932, 22225425, 24209605, 12606074, 14512541, 9334930, 12044299, 15105534, 18190677, 26691901, 8971044, 9820136, 19675185, 17425435, 19956987, 31268416, 32605035, 34965217 (CLIP4), 38361825, others Tula virus.\n\n**EXCLUDE (CLIP4 papers):** 28418867, 29901187, 27283491, 33968748, 30465911, 31200661 (Tula in China), 34320644 (TULV/Leptospira), 35212154 (ALK-CLIP4), 39121973 (miR-135b/CLIP4), 33575272 (CLIP4 breast cancer), 39920578 (CLIP4 HCC), 34965217 (CLIP4 scores).\n\n**EXCLUDE (TULA-2/UBASH3B paralog-only):** PMID:20585042, 18570454 (exosomes), 23149425 (TULA-2 osteoclasts), 20670933 (TULA-2 substrate specificity — does test TULA-1 activity too → partial KEEP), 22267732 (TULA-2 in mast cells), 27609517 (TULA-2 Syk Y346), 31249969 (TULA-2 CLEC-2), 27765766 (TULA-2 FcγRIIA), 25211447 (UBASH3A thyroid assoc — no mechanism).\n\nNote: PMID:20670933 tests TULA-1 (=UBASH3A) showing no detectable activity — KEEP for that finding.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"UBASH3A (also called TULA/STS-2) was identified as a novel gene on chromosome 21q22.3 encoding a 661-amino-acid protein with a unique combination of an SH3 domain, a ubiquitin-associated (UBA) domain, and a novel phosphoglycerate mutase-like domain containing a nuclear localization signal. Expression was found to be restricted to spleen, peripheral blood leukocytes, and bone marrow, suggesting lymphoid-specific expression.\",\n      \"method\": \"cDNA cloning, domain analysis, semi-quantitative RT-PCR across tissues\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original gene isolation with domain characterization; foundational paper\",\n      \"pmids\": [\"11281453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Sts-2 (UBASH3A) and Sts-1 negatively regulate TCR signaling: T cells from Sts-1/2 double-knockout mice are hyperresponsive to TCR stimulation, exhibiting increased ZAP-70 phosphorylation (including ubiquitylated forms) and hyperactivation of downstream signaling proteins, leading to increased cytokine production and increased susceptibility to autoimmunity in an EAE mouse model.\",\n      \"method\": \"Double-knockout mouse generation, T cell stimulation assays, immunoblotting for phospho-ZAP-70, cytokine production assays, EAE model\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple readouts in vivo and in vitro\",\n      \"pmids\": [\"14738763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TULA (UBASH3A/STS-2) binds directly to c-Cbl via its SH3 domain, binds mono-ubiquitin and EGFR/ubiquitin chimera via its UBA domain, and inhibits c-Cbl-mediated downregulation of EGFR in 293T cells. TULA overexpression in Jurkat T cells upregulates ZAP-70 kinase activity and NF-AT transcription factor activity, suggesting it counteracts c-Cbl-mediated suppression of protein tyrosine kinases by promoting ubiquitylation and degradation of c-Cbl.\",\n      \"method\": \"Affinity chromatography, mass spectrometry, co-immunoprecipitation, co-expression in 293T cells, Jurkat T-cell overexpression/knockdown assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP plus functional cell-based assays in single lab\",\n      \"pmids\": [\"15107835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TULA (UBASH3A/STS-2) and Sts-1 are recruited into activated EGFR complexes upon ligand stimulation, inhibit receptor internalization (reducing the number of EGFR-containing endocytic vesicles), block receptor degradation, and thereby prolong activation of mitogenic signaling pathways. The SH3 domain mediates Cbl binding; the UBA domain binds mono-ubiquitin and EGFR/Ub chimera; the PGM domain mediates Sts-1/2 oligomerization.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative interference, fluorescence microscopy, endocytosis assays, cell proliferation and transformation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, domain-function mapping, confirmed in multiple cell systems\",\n      \"pmids\": [\"15159412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TULA (UBASH3A) inhibits clathrin-dependent endocytosis of transferrin and LDL, and clathrin-independent but dynamin-dependent endocytosis of CD59 and MHC-I, but does not affect dynamin-independent uptake of ricin. TULA co-immunoprecipitates and colocalizes with dynamin, and the inhibitory effect on endocytosis is counteracted by overexpression of dynamin, indicating that the SH3 domain of TULA sequesters dynamin via its proline-rich sequences.\",\n      \"method\": \"Endocytosis assays (Tf, LDL, CD59, MHC-I, ricin uptake), co-immunoprecipitation of TULA and dynamin, rescue experiments with dynamin overexpression, domain mapping\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple cargo types tested, rescue experiments, mechanistic domain assignment; replicated across multiple cargo types\",\n      \"pmids\": [\"17382318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TULA (UBASH3A) promotes T cell apoptosis independently of TCR/CD3 signaling and caspase activity. Mass spectrometry identified apoptosis-inducing factor (AIF) as a TULA-interacting protein; RNAi knockdown of AIF abolishes the apoptotic effect of TULA. Subcellular localization and functional analysis of TULA mutants indicate that TULA enhances AIF-mediated caspase-independent apoptosis, likely by facilitating AIF interactions with co-factors.\",\n      \"method\": \"Mass spectrometry-based protein interaction analysis, siRNA knockdown of AIF, apoptosis assays (caspase-independent), subcellular localization, TULA mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-identified interaction validated by functional rescue (siRNA), multiple orthogonal approaches in single study\",\n      \"pmids\": [\"17709377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TULA (UBASH3A/STS-2) proteins bind to ABCE-1 (also known as RLI/HP68, a host factor for HIV-1 assembly) as identified by mass spectrometry, and substantially inhibit production of both sub-genomic and full-length HIV-1 viral particles. The anti-HIV-1 effect requires the UBA domain of TULA, and ABCE-1 appears to recruit TULA to sites of HIV-1 assembly where it disrupts ubiquitylation-dependent steps of the HIV-1 life cycle.\",\n      \"method\": \"Mass spectrometry identification of TULA-associated proteins, HIV-1 production assays, UBA domain deletion mutants, co-localization studies\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — MS-identified interaction, UBA domain mutagenesis, functional HIV production assay; single lab\",\n      \"pmids\": [\"18006034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Sts-2 (UBASH3A) undergoes monoubiquitination via an intramolecular mechanism: the UBA domain of Sts-2 binds to the attached ubiquitin moiety, preventing Sts-2 from binding in trans to ubiquitinated targets. Permanent monoubiquitination (mimicked by ubiquitin fusion to the C-terminus) impairs the ability of Sts-2 to regulate trafficking of ubiquitinated receptors. The in vivo monoubiquitination site of Sts-2 was mapped, and its mutation enhances Sts-2-mediated effects on EGFR downregulation.\",\n      \"method\": \"Monoubiquitination site mapping, ubiquitin fusion constructs, co-immunoprecipitation, EGFR trafficking assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic mapping of PTM site with functional consequences, multiple orthogonal approaches\",\n      \"pmids\": [\"16429130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sts-2 (UBASH3A), in contrast to Sts-1, stabilizes EGFR in a signaling-competent (phosphorylated) state: Sts-2 UBA domain contributes to receptor stabilization, but the PGM domain of Sts-2 lacks the dephosphorylation activity toward EGFR that Sts-1 PGM possesses. Thus Sts-1 and Sts-2 inhibit EGFR degradation via mechanistically distinct pathways.\",\n      \"method\": \"Domain swap and deletion experiments, EGFR phosphorylation and degradation assays, comparison of Sts-1 and Sts-2 PGM phosphatase activity toward EGFR\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — comparative domain analysis with functional readouts; distinguishes Sts-2 mechanism from Sts-1\",\n      \"pmids\": [\"17880946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sts-2 (UBASH3A) undergoes E3-independent monoubiquitination: the UBA domain directly cooperates with Ub-charged E2 enzymes to promote monoubiquitination in the absence of E3 ligases. FRET and siRNA studies confirmed that Ub-loaded E2 and Sts-2 interact in cells and that E2 enzymes are essential for their monoubiquitination in vivo.\",\n      \"method\": \"E3-independent ubiquitination assays in vitro, FRET, siRNA knockdown, in vivo ubiquitination assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution plus in vivo validation with FRET and siRNA\",\n      \"pmids\": [\"17588522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TULA (UBASH3A/STS-2) has negligible phosphatase activity toward tyrosine-phosphorylated Syk compared to TULA-2. Overexpression of TULA increases Syk tyrosine phosphorylation in cells co-transfected with Syk, suggesting TULA acts as a dominant-negative inhibitor of TULA-2-dependent Syk dephosphorylation. Thus TULA and TULA-2 exert opposing effects on Syk phosphorylation.\",\n      \"method\": \"In vitro phosphatase assays with Syk substrate, co-transfection overexpression in cells, immunoblotting for phospho-Syk, dominant-negative mutant analysis\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro phosphatase assays plus cell-based overexpression; single lab\",\n      \"pmids\": [\"18189269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The crystal structure of the PGM (2H-phosphatase) domain of Sts-2 (UBASH3A) was solved in apo, tungstate-bound, and phosphate-bound forms, showing strong structural similarity to Sts-1 PGM including conservation of all catalytic residues. The active site shows pH optimum at 5.0 (acid-dependent phosphatase). Non-conserved residues Gln372, Ala446, Glu481, Ser552, and Ser582 account for the reduced activity relative to Sts-1: mutating these to Sts-1 equivalents substantially increases Sts-2 PGM activity.\",\n      \"method\": \"X-ray crystallography (apo, tungstate-bound, phosphate-bound structures), phosphatase kinetics, site-directed mutagenesis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures plus mutagenesis defining catalytic mechanism and specificity determinants\",\n      \"pmids\": [\"19196006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structures of the Sts-2 (UBASH3A) PGM domain in its phosphorylated form and bound to vanadate (transition-state analogue) reveal that His366 is the nucleophilic residue transiently phosphorylated during catalysis. The V-NE2 bond length (2.25 Å) indicates a partially associative reaction mechanism. Glu476 plays a role in activating a uniquely positioned water molecule for dephosphorylation.\",\n      \"method\": \"X-ray crystallography of phospho-intermediate and VO3-bound transition state analogue, bond length analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures of reaction intermediates directly defining catalytic mechanism\",\n      \"pmids\": [\"19627098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TULA-1 (UBASH3A) showed no detectable phosphatase activity toward any phosphotyrosyl peptides in a combinatorial library screen, in contrast to TULA-2 which showed activity toward two peptide classes. This establishes that UBASH3A lacks significant intrinsic phosphatase activity against the substrates tested.\",\n      \"method\": \"Combinatorial phosphotyrosyl peptide library screening, kinetic analysis of representative peptide substrates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic in vitro assay across large peptide library; clearly negative result for UBASH3A\",\n      \"pmids\": [\"20670933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Sts-2 (UBASH3A) regulates the level of tyrosine phosphorylation on ZAP-70 in T cells. The PGM domain of Sts-2 has clear but weak phosphatase activity detectable with appropriate substrates. Residues Glu-481, Ser-552, and Ser-582 are specificity determinants: a triple mutant converting these to their Sts-1 counterparts substantially increases Sts-2 phosphatase activity, suggesting the two homologs cooperate independently to set the TCR activation threshold.\",\n      \"method\": \"T cell phosphorylation assays, in vitro phosphatase activity with new substrates, site-directed mutagenesis of active site residues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro enzyme assays with mutagenesis plus cell-based phosphorylation readouts\",\n      \"pmids\": [\"21393235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nrdp1 E3 ligase mediates K33-linked polyubiquitination of ZAP-70 and promotes its dephosphorylation by Sts-1 and Sts-2 (UBASH3A), thereby terminating early TCR signaling in CD8+ T cells. Nrdp1 physically interacts with ZAP-70 and with both Sts proteins, linking K33-ubiquitin modification of ZAP-70 to Sts-mediated dephosphorylation.\",\n      \"method\": \"K33 polyubiquitination assays, co-immunoprecipitation, Nrdp1 knockout mice, T cell activation assays, ZAP-70 phosphorylation analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo KO plus biochemical reconstitution of ubiquitin-linked dephosphorylation, replicated with multiple approaches\",\n      \"pmids\": [\"26390156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UBASH3A attenuates NF-κB signaling downstream of TCR stimulation by specifically suppressing activation of the IκB kinase (IKK) complex. Novel interactions of UBASH3A with non-degradative polyubiquitin chains, TAK1, and NEMO were identified, suggesting an ubiquitin-dependent mechanism of NF-κB pathway regulation. T1D risk alleles at rs11203203 and rs80054410 increase UBASH3A expression in primary CD4+ T cells upon TCR stimulation, resulting in reduced IKK activation and decreased IL-2 gene expression.\",\n      \"method\": \"siRNA knockdown and overexpression in primary human CD4+ T cells, IKK complex activity assays, co-immunoprecipitation of UBASH3A with polyubiquitin chains/TAK1/NEMO, IL-2 production assays, allele-specific expression studies\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods (Co-IP, kinase assay, gene expression) in primary human T cells; functional allele-specific validation\",\n      \"pmids\": [\"28607106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human Sts-2 (UBASH3A) histidine phosphatase domain (Sts-2HP) crystal structure was solved to 2.4 Å with sulfate bound; steady-state kinetics confirm that Sts-2HP has significantly lower phosphatase activity than Sts-1HP (human proteins behave similarly to mouse). The PHPS1 inhibitor (known SHP-1 inhibitor) inhibits Sts-1 with Ki = 1.05 μM, and human Sts-1 shows robust phosphatase activity against ZAP-70 in a cell-based assay.\",\n      \"method\": \"X-ray crystallography of human Sts-2HP, steady-state kinetic analysis, inhibitor testing, cell-based ZAP-70 dephosphorylation assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure of human protein with kinetic characterization and cell-based validation\",\n      \"pmids\": [\"28759203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"UBASH3A noncoding variant rs1893592 plays a novel role in T1D: its minor allele is associated with reduced overall UBASH3A mRNA levels and increased proportion of an intron-9-retaining, non-functional transcript in primary CD4+ T cells upon TCR stimulation. This reduction in UBASH3A protein leads to increased IL-2 secretion, demonstrating that noncoding variants regulate UBASH3A expression and thereby T cell function.\",\n      \"method\": \"Haplotype analysis, allele-specific expression assays, RNA-seq in primary human CD4+ T cells, IL-2 secretion assays, splice-form quantification\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — allele-specific expression and functional IL-2 readout in primary cells; single study\",\n      \"pmids\": [\"29491471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UBASH3A regulates TCR-CD3 complex synthesis and turnover: modulation of UBASH3A levels in unstimulated Jurkat cells alters total cellular CD3 chain amounts and cell-surface TCR-CD3 levels (but not CD28 levels). Upon TCR engagement, UBASH3A enhances downmodulation of surface TCR-CD3. Mass spectrometry and protein-protein interaction studies reveal novel associations between UBASH3A and components of ER-associated protein degradation (ERAD), cell motility, endocytosis, and endocytic recycling pathways. The SH3 domain of UBASH3A mediates binding to CBL-B, an E3 ubiquitin ligase that negatively regulates CD28-mediated signaling.\",\n      \"method\": \"UBASH3A modulation (overexpression/knockdown) in Jurkat cells, flow cytometry for surface TCR-CD3 and CD28, mass spectrometry interactome, co-immunoprecipitation, SH3 domain binding assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (flow cytometry, MS interactome, Co-IP, domain mapping) in single comprehensive study\",\n      \"pmids\": [\"31659016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"UBASH3A deficiency in NOD mice accelerates type 1 diabetes development in both sexes, is associated with increased β-cell autoreactive T cells in spleen and pancreatic lymph nodes, and promotes salivary gland inflammation in females. Adoptive transfer of UBASH3A-deficient splenic T cells into NOD.Rag1-/- mice was sufficient to promote T1D development, establishing that UBASH3A's protective effect is T cell-intrinsic.\",\n      \"method\": \"Zinc-finger nuclease-mediated knockout in NOD mice, diabetes incidence monitoring, insulitis scoring, flow cytometry for autoreactive T cells, adoptive transfer experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with adoptive transfer establishing T cell-intrinsic mechanism, multiple phenotypic readouts\",\n      \"pmids\": [\"32694640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In rheumatoid arthritis CD4+ T cells, UBASH3A transcription is suppressed via epigenetic dysregulation of a super-enhancer: BACH2 (a silencing transcription factor) accumulates at UBASH3A loci while MED1/BRD4 (SE-defining factors) are reduced. Knockdown of enhancer RNAs (eRNA_1, eRNA_3) reduces UBASH3A mRNA. UBASH3A overexpression in RA patient CD4+ T cells significantly inhibits TCR-stimulated IL-6 production.\",\n      \"method\": \"ChIP for BACH2, MED1, BRD4 at UBASH3A loci, locked nucleic acid-mediated eRNA knockdown, RT-PCR, western blotting, UBASH3A overexpression in CD4+ T cells, cytometric bead array for IL-6\",\n      \"journal\": \"Inflammation and regeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional overexpression with cytokine readout; single lab in patient samples\",\n      \"pmids\": [\"36324153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UBASH3A physically interacts with PTPN22 in T cells via its SH3 domain, as demonstrated by co-immunoprecipitation. This interaction is not altered by the T1D risk coding variant rs2476601 in PTPN22. RNA-seq analysis of T1D cases shows that UBASH3A and PTPN22 transcript levels have a cooperative effect on IL-2 expression in primary CD8+ T cells, and the two T1D risk variants rs11203203 (UBASH3A) and rs2476601 (PTPN22) interact statistically to jointly affect T1D risk.\",\n      \"method\": \"Co-immunoprecipitation in T cells, SH3 domain binding assays, RNA-seq analysis of primary CD8+ T cells, genetic interaction analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP plus RNA-seq functional analysis and genetic interaction; single lab\",\n      \"pmids\": [\"37240014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FLI1 indirectly inhibits UBASH3A transcription via GATA2, thereby promoting erythroleukemia cell growth. UBASH3A knockdown in erythroleukemic cells increased proliferation, associated with dramatic induction of HSP70 gene HSPA1B; knockdown of HSPA1B accelerated leukemic cell proliferation, suggesting UBASH3A acts as a tumor suppressor in erythroleukemia partly by activating HSPA1B expression. Overexpression of UBASH3A across cancers is associated with good prognosis.\",\n      \"method\": \"ChIP analysis and luciferase assays for UBASH3A promoter, lentivirus-shRNA knockdown, RNA-seq, MTT proliferation assays, flow cytometry for apoptosis\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — promoter ChIP, functional KD with defined proliferation phenotype and mechanistic link to HSPA1B; single lab\",\n      \"pmids\": [\"38461240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Germline knockout of Ubash3a in LEW.1W rats (which carry RT1B/Du MHC but are normally T1D-resistant) renders these rats relatively susceptible to autoimmune diabetes, demonstrating that UBASH3A provides a critical immunoregulatory checkpoint downstream of the T cell receptor that protects against autoimmunity even in the context of a susceptible MHC haplotype.\",\n      \"method\": \"Germline Ubash3a knockout in LEW.1W rats, diabetes incidence monitoring, Tcrb-V13S1A1 knockout comparison, in silico structural modeling of TCR-MHC interaction\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO in defined genetic background with diabetes phenotype; functional epistasis with TCR gene\",\n      \"pmids\": [\"34205929\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UBASH3A (TULA/STS-2) is a lymphoid-enriched multi-domain adaptor/phosphatase that negatively regulates T cell activation through at least two distinct mechanisms: (1) its SH3 domain binds c-Cbl, CBL-B, PTPN22, dynamin, and non-degradative polyubiquitin chains/TAK1/NEMO to suppress NF-κB/IKK signaling, inhibit dynamin-dependent endocytosis, and modulate TCR-CD3 complex synthesis and turnover; (2) its PGM/2H-phosphatase domain has weak acid-dependent phosphatase activity (with His366 as the nucleophilic residue) that contributes modestly to ZAP-70 dephosphorylation in cooperation with the more active paralog UBASH3A/STS-1; additionally, UBASH3A promotes caspase-independent T cell apoptosis via interaction with AIF, undergoes UBA domain-dependent E3-independent monoubiquitination that limits its own ubiquitin-binding activity, and its UBA domain recruits it to HIV-1 assembly sites to inhibit viral budding.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"UBASH3A is a lymphoid-enriched multidomain adaptor protein that sets the activation threshold of T cells by negatively regulating TCR-proximal signaling, NF-κB pathway activation, and TCR-CD3 complex turnover. Its SH3 domain mediates interactions with dynamin, CBL-B, and PTPN22 to inhibit endocytosis and modulate receptor trafficking, while its UBA domain binds ubiquitin and non-degradative polyubiquitin chains to engage TAK1 and NEMO, thereby suppressing IKK-dependent NF-κB signaling and IL-2 production [PMID:28607106, PMID:31659016, PMID:17382318, PMID:37240014]. Although UBASH3A possesses a histidine phosphatase (PGM/2H) domain, its intrinsic catalytic activity is negligible compared to its paralog UBASH3B; structural and mutagenesis studies identify specific active-site residues responsible for this difference, and UBASH3A can act as a dominant-negative antagonist of UBASH3B phosphatase function [PMID:19196006, PMID:20670933, PMID:18189269]. Loss of UBASH3A in mice causes T-cell hyperresponsiveness that accelerates autoimmune diabetes, colitis, and arthritis, and human type 1 diabetes risk alleles increase UBASH3A expression to suppress IL-2, directly implicating UBASH3A dosage in autoimmune susceptibility [PMID:32694640, PMID:28607106, PMID:29491471, PMID:25047644].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of UBASH3A as a novel lymphoid-enriched gene encoding the first protein with both UBA and SH3 domains plus a PGM-like domain established the gene's domain architecture and hematopoietic expression pattern, framing subsequent functional studies.\",\n      \"evidence\": \"cDNA cloning, domain prediction, and RT-PCR tissue expression profiling\",\n      \"pmids\": [\"11281453\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional data at this stage\", \"Nuclear localization signal noted but nuclear function never validated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Knockout studies established that UBASH3A (with its paralog UBASH3B) is a physiological negative regulator of TCR signaling: double-KO T cells showed hyperphosphorylation of ZAP-70, elevated cytokine production, and increased susceptibility to EAE, resolving whether the gene suppresses or promotes T-cell activation.\",\n      \"evidence\": \"Sts-1/Sts-2 double-KO mice, T-cell stimulation assays, ZAP-70 phosphorylation, EAE model\",\n      \"pmids\": [\"14738763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contribution of UBASH3A vs. UBASH3B not separated in double KO\", \"Mechanism of ZAP-70 regulation unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Domain-specific interaction studies showed that the SH3 domain binds Cbl family E3 ligases and the UBA domain binds ubiquitin/ubiquitinated receptors, and that UBASH3A inhibits receptor internalization, establishing its role as a multivalent adaptor in endocytic trafficking.\",\n      \"evidence\": \"Affinity chromatography, Co-IP, domain dissection, EGFR endocytosis assays in 293T and Jurkat cells\",\n      \"pmids\": [\"15107835\", \"15159412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relevance of EGFR regulation to lymphoid biology unclear\", \"Whether endocytic inhibition applies to TCR not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The mechanism of endocytic inhibition was resolved: UBASH3A's SH3 domain binds and functionally sequesters dynamin, blocking both clathrin-dependent and clathrin-independent endocytosis, explaining how it can broadly regulate receptor turnover.\",\n      \"evidence\": \"Co-IP of UBASH3A–dynamin, endocytosis assays for multiple cargo, dynamin overexpression rescue\",\n      \"pmids\": [\"17382318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether dynamin sequestration occurs at endogenous UBASH3A expression levels not determined\", \"Relative contribution of dynamin vs. Cbl binding to TCR regulation unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Biochemical comparison showed UBASH3A has negligible phosphatase activity relative to UBASH3B and can act as a dominant-negative inhibitor of UBASH3B-mediated Syk dephosphorylation, reframing UBASH3A as primarily an adaptor rather than a catalytic phosphatase.\",\n      \"evidence\": \"In vitro phosphatase assays, co-transfection overexpression, Syk phosphorylation analysis\",\n      \"pmids\": [\"18189269\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dominant-negative model based on overexpression; stoichiometry at endogenous levels unknown\", \"Whether UBASH3A has any physiologically relevant phosphatase substrates remains open\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystal structures of the UBASH3A PGM/2H-phosphatase domain in multiple catalytic states revealed the nucleophilic histidine mechanism and identified five non-conserved active-site residues (Gln372, Ala446, Glu481, Ser552, Ser582) that explain its weak catalytic activity relative to UBASH3B.\",\n      \"evidence\": \"X-ray crystallography (apo, tungstate, phosphate, phospho-His intermediate, vanadate forms), mutagenesis, enzyme kinetics\",\n      \"pmids\": [\"19196006\", \"19627098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No physiological protein substrate identified for UBASH3A phosphatase activity\", \"In vivo relevance of catalytic activity vs. adaptor function not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Systematic peptide library screening confirmed UBASH3A has no detectable activity toward any phosphotyrosyl peptide, while UBASH3B efficiently dephosphorylates Syk, definitively establishing a catalytic asymmetry between the paralogs.\",\n      \"evidence\": \"Combinatorial phosphotyrosyl peptide library, kinetic analysis, UBASH3B-KO platelet validation\",\n      \"pmids\": [\"20670933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Non-peptide substrates (e.g., phospholipids) not tested\", \"Whether UBASH3A contributes to ZAP-70 regulation through a non-catalytic mechanism not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Single-KO studies in a colitis model separated the individual contribution of UBASH3A from UBASH3B: UBASH3A-KO alone exacerbated inflammatory bowel disease with enhanced T-cell responses, demonstrating a non-redundant anti-inflammatory role.\",\n      \"evidence\": \"TNBS-induced colitis in single and double KO mice, flow cytometry, TCR signaling analysis\",\n      \"pmids\": [\"25047644\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of non-redundancy with UBASH3B not fully delineated\", \"Adaptive vs. innate contributions not separated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"A second major signaling axis was uncovered: UBASH3A suppresses NF-κB by interacting with polyubiquitin chains, TAK1, and NEMO to inhibit IKK activation; T1D risk variants that increase UBASH3A expression diminish NF-κB–driven IL-2 production, directly linking gene dosage to autoimmune risk.\",\n      \"evidence\": \"Co-IP (UBASH3A–TAK1, –NEMO, –polyubiquitin), siRNA/overexpression in primary human CD4+ T cells, NF-κB reporter, IL-2 measurement\",\n      \"pmids\": [\"28607106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ubiquitin-binding site on UBA domain for non-degradative chains not structurally mapped\", \"Whether TAK1/NEMO interaction is direct or ubiquitin-scaffolded unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The protective T1D allele rs1893592 was shown to reduce functional UBASH3A protein by promoting an intron-retaining splice variant, linking alternative splicing to IL-2 recovery and disease protection, and confirming dosage as the key variable.\",\n      \"evidence\": \"Haplotype analysis, RNA-seq, allele-specific expression in primary human CD4+ T cells\",\n      \"pmids\": [\"29491471\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stability and fate of the intron-9-retaining transcript not fully characterized\", \"Whether the truncated protein has any residual function is unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"UBASH3A was shown to regulate TCR-CD3 complex abundance and stimulus-dependent surface downmodulation through its SH3 domain–mediated interaction with CBL-B, linking its adaptor function to both ER-associated degradation and endocytic recycling of the TCR.\",\n      \"evidence\": \"Flow cytometry, mass spectrometry interactome, SH3 domain binding assays, siRNA/overexpression in Jurkat cells\",\n      \"pmids\": [\"31659016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UBASH3A–CBL-B interaction promotes ubiquitination of CD3 chains not directly tested\", \"Relative contributions of ERAD vs. endocytic pathways not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"UBASH3A deficiency in NOD mice accelerated T1D in a T-cell-intrinsic manner (shown by adoptive transfer), providing definitive in vivo genetic proof that UBASH3A restrains autoreactive T cells and protects against diabetes.\",\n      \"evidence\": \"ZFN-generated NOD-UBASH3A-KO, diabetes incidence, adoptive transfer into NOD.Rag1−/−\",\n      \"pmids\": [\"32694640\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether acceleration reflects enhanced TCR signaling, NF-κB, or both pathways not dissected\", \"Effect on regulatory T cells not examined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"UBASH3A was shown to physically interact with PTPN22 via its SH3 domain, and their transcript levels cooperatively regulate IL-2 in CD8+ T cells, with genetic interaction at T1D risk loci, expanding the adaptor network through which UBASH3A calibrates T-cell activation.\",\n      \"evidence\": \"Co-IP, SH3 domain binding, RNA-seq, genetic association analysis in human cohorts\",\n      \"pmids\": [\"37240014\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single Co-IP without reciprocal pull-down for PTPN22 interaction\", \"Functional consequence of UBASH3A–PTPN22 complex on TCR signaling not biochemically dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved whether UBASH3A exerts its negative regulatory effect primarily through adaptor-mediated NF-κB suppression, dynamin/CBL-B–dependent receptor trafficking, dominant-negative inhibition of UBASH3B, or a combination, and whether it has any physiologically relevant catalytic activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Relative contribution of each domain (SH3, UBA, PGM) to T-cell phenotype not genetically dissected in vivo\", \"No physiological phosphatase substrate identified despite structural characterization\", \"Whether UBASH3A functions differently in CD4+ vs. CD8+ T cells or other immune lineages is largely unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 2, 3, 9, 10, 16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 9, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2, 3, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 9, 14, 15, 17, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 9, 18]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 3, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CBL\",\n      \"CBLB\",\n      \"DNM2\",\n      \"TAK1\",\n      \"NEMO\",\n      \"PTPN22\",\n      \"UBASH3B\",\n      \"ABCE1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"UBASH3A (TULA/STS-2) is a lymphoid-enriched multi-domain adaptor protein that functions as a negative regulator of T cell receptor signaling and immune activation. Its SH3 domain mediates interactions with c-Cbl, CBL-B, PTPN22, dynamin, and NF-κB pathway components (TAK1, NEMO, non-degradative polyubiquitin chains), through which UBASH3A suppresses IKK/NF-κB activation, inhibits dynamin-dependent endocytosis, modulates TCR-CD3 complex synthesis and surface turnover, and cooperates with PTPN22 to set the TCR activation threshold [PMID:28607106, PMID:17382318, PMID:31659016, PMID:37240014]. Its PGM/2H-phosphatase domain possesses weak, acid-dependent phosphatase activity (His366 as nucleophilic residue) that contributes modestly to ZAP-70 dephosphorylation—substantially less than its paralog UBASH3B/STS-1—while its UBA domain undergoes E3-independent monoubiquitination that limits its own ubiquitin-binding capacity and regulates receptor trafficking [PMID:19196006, PMID:19627098, PMID:21393235, PMID:17588522]. Loss of UBASH3A in NOD mice and LEW.1W rats accelerates autoimmune diabetes development through a T cell-intrinsic mechanism, and type 1 diabetes risk alleles increase UBASH3A expression in stimulated CD4+ T cells, establishing UBASH3A as a causal immunoregulatory checkpoint gene for T1D [PMID:32694640, PMID:34205929, PMID:28607106].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of UBASH3A as a novel lymphoid-restricted gene with a unique SH3–UBA–PGM domain architecture established the molecular foundation for its study as a potential immune signaling regulator.\",\n      \"evidence\": \"cDNA cloning, domain analysis, and tissue-restricted RT-PCR expression profiling\",\n      \"pmids\": [\"11281453\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No function assigned; domain activities unknown\", \"Expression at protein level in lymphocyte subsets not confirmed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genetic ablation of Sts-1 and Sts-2 in mice revealed that the two paralogs cooperate to negatively regulate TCR signaling, with double-knockout T cells showing hyperphosphorylated ZAP-70, increased cytokine production, and susceptibility to autoimmunity, establishing the core physiological role of the family.\",\n      \"evidence\": \"Double-knockout mouse T cells with phospho-ZAP-70 immunoblotting, cytokine assays, and EAE autoimmune model\",\n      \"pmids\": [\"14738763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contributions of Sts-1 vs Sts-2 not separated in the double KO\", \"Mechanism of ZAP-70 regulation (direct dephosphorylation vs adaptor function) unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Biochemical dissection showed that UBASH3A's SH3 domain binds c-Cbl and its UBA domain binds monoubiquitin, and that UBASH3A inhibits Cbl-mediated receptor downregulation and dynamin-dependent endocytosis, defining two key molecular interaction modes.\",\n      \"evidence\": \"Co-IP, mass spectrometry, EGFR trafficking assays, and endocytosis assays with multiple cargo types including dynamin rescue\",\n      \"pmids\": [\"15107835\", \"15159412\", \"17382318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological significance of endocytosis inhibition in lymphocytes not demonstrated\", \"Relative importance of Cbl-binding versus dynamin-sequestration in T cell context unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that UBASH3A undergoes E3-independent monoubiquitination—with its own UBA domain directly cooperating with Ub-charged E2 enzymes—revealed a self-regulatory switch: monoubiquitinated UBASH3A loses the ability to bind ubiquitinated targets in trans, tuning its adaptor activity.\",\n      \"evidence\": \"In vitro E3-independent ubiquitination reconstitution, FRET, siRNA, ubiquitin fusion constructs, and EGFR trafficking assays\",\n      \"pmids\": [\"16429130\", \"17588522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of E2 enzyme(s) responsible in T cells not defined\", \"Dynamics of monoubiquitination/deubiquitination cycle in vivo unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of AIF as a UBASH3A-interacting protein and demonstration that UBASH3A promotes caspase-independent apoptosis via AIF revealed a pro-apoptotic function distinct from its TCR-signaling role, while interaction with ABCE-1 and UBA-dependent inhibition of HIV-1 budding uncovered an antiviral function.\",\n      \"evidence\": \"Mass spectrometry interaction screens, AIF siRNA rescue of apoptosis, HIV-1 production assays with UBA domain mutants\",\n      \"pmids\": [\"17709377\", \"18006034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of AIF-mediated apoptosis in T cell homeostasis not confirmed in vivo\", \"Anti-HIV activity studied only in overexpression systems\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystal structures of the UBASH3A PGM domain in apo, substrate-bound, phospho-intermediate, and transition-state forms established that His366 is the catalytic nucleophile and identified five non-conserved residues (Gln372, Ala446, Glu481, Ser552, Ser582) whose divergence from UBASH3B explains the dramatically lower phosphatase activity of UBASH3A.\",\n      \"evidence\": \"X-ray crystallography of multiple catalytic intermediates, site-directed mutagenesis restoring activity, pH-rate profiling\",\n      \"pmids\": [\"19196006\", \"19627098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrate identity for UBASH3A phosphatase domain remains uncertain\", \"Whether the weak phosphatase activity is biologically meaningful independent of the adaptor functions is unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Direct measurement confirmed that UBASH3A possesses weak but detectable phosphatase activity toward ZAP-70, and combinatorial peptide library screening showed no activity against a broad phosphotyrosyl panel, resolving the long-standing question of whether UBASH3A functions primarily as a phosphatase or as an adaptor.\",\n      \"evidence\": \"Combinatorial phosphopeptide library screen (negative result), T cell phospho-ZAP-70 assays, mutagenesis of specificity determinants\",\n      \"pmids\": [\"20670933\", \"21393235\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UBASH3A contributes to ZAP-70 dephosphorylation in vivo through direct activity or by recruiting UBASH3B/Nrdp1 remains debated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that Nrdp1 E3 ligase mediates K33-linked polyubiquitination of ZAP-70 and promotes its dephosphorylation by both Sts-1 and Sts-2 provided a molecular link between ubiquitin signaling and phosphatase-mediated TCR signal termination.\",\n      \"evidence\": \"K33 polyubiquitination assays, co-IP of Nrdp1/ZAP-70/Sts proteins, Nrdp1 knockout mice, T cell activation assays\",\n      \"pmids\": [\"26390156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UBASH3A's UBA domain directly recognizes K33-linked chains on ZAP-70 is not shown\", \"Relative contribution of UBASH3A vs UBASH3B in Nrdp1-dependent dephosphorylation not quantified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of UBASH3A as a suppressor of NF-κB/IKK signaling through novel interactions with non-degradative polyubiquitin chains, TAK1, and NEMO, combined with the finding that T1D risk alleles increase UBASH3A expression and reduce IL-2 production, established a distinct signaling axis beyond ZAP-70 dephosphorylation.\",\n      \"evidence\": \"siRNA/overexpression in primary human CD4+ T cells, IKK activity assays, co-IP with TAK1/NEMO/polyubiquitin, allele-specific expression\",\n      \"pmids\": [\"28607106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TAK1/NEMO interaction is direct or ubiquitin-mediated is not fully resolved\", \"Structural basis of SH3 domain recognition of TAK1/NEMO unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that UBASH3A controls steady-state TCR-CD3 complex levels and surface turnover, and identification of CBL-B and ERAD pathway components as interactors, expanded the functional model beyond signal transduction to receptor homeostasis.\",\n      \"evidence\": \"Flow cytometry for surface TCR-CD3 upon UBASH3A modulation, mass spectrometry interactome, co-IP of CBL-B via SH3 domain\",\n      \"pmids\": [\"31659016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UBASH3A promotes TCR-CD3 degradation through ERAD or endolysosomal pathways is unclear\", \"Interactome not validated for all hits beyond CBL-B\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"UBASH3A knockout in NOD mice and LEW.1W rats accelerated autoimmune diabetes with increased β-cell autoreactive T cells, and adoptive transfer demonstrated a T cell-intrinsic protective mechanism, providing in vivo genetic proof that UBASH3A is a causal checkpoint gene for type 1 diabetes.\",\n      \"evidence\": \"Zinc-finger nuclease KO in NOD mice, germline KO in LEW.1W rats, diabetes incidence, insulitis scoring, adoptive transfer into Rag1−/− hosts\",\n      \"pmids\": [\"32694640\", \"34205929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which UBASH3A-dependent pathway (NF-κB suppression, TCR-CD3 turnover, ZAP-70 dephosphorylation, or apoptosis) is most critical for T1D protection is unresolved\", \"Human validation of knockout phenotype not available\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Physical interaction of UBASH3A with PTPN22 via the SH3 domain and cooperative effects of their T1D risk variants on IL-2 expression revealed functional epistasis between two major T1D susceptibility genes at the protein level.\",\n      \"evidence\": \"Co-IP in T cells, SH3 domain binding assays, RNA-seq of primary CD8+ T cells, genetic interaction analysis\",\n      \"pmids\": [\"37240014\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of UBASH3A–PTPN22 interaction on phosphatase activity or substrate access not defined\", \"Reciprocal co-IP not shown\", \"Whether interaction occurs at the immunological synapse is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of UBASH3A as a tumor suppressor in erythroleukemia, acting downstream of FLI1/GATA2 to activate HSPA1B and suppress proliferation, extended UBASH3A's functional repertoire beyond lymphocyte regulation.\",\n      \"evidence\": \"ChIP and luciferase reporter for UBASH3A promoter, shRNA knockdown, RNA-seq, proliferation assays in erythroleukemic cells\",\n      \"pmids\": [\"38461240\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which UBASH3A activates HSPA1B transcription is unknown\", \"Tumor-suppressive role not validated in vivo\", \"Whether this function involves the same domains as immune regulation is unstudied\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The relative contributions of UBASH3A's adaptor functions (NF-κB suppression, TCR-CD3 turnover, endocytosis inhibition) versus its weak phosphatase activity to T cell homeostasis and autoimmune disease protection remain to be dissected in vivo with domain-specific mutants.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No domain-specific knock-in models exist to separate adaptor from phosphatase function in vivo\", \"No structural model of full-length UBASH3A or its multi-domain complexes\", \"Therapeutic potential of modulating UBASH3A expression or activity in autoimmunity is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [11, 12, 14]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 3, 16, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 16, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 3, 19]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 15, 16, 20, 22]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 16, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [20, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CBL\",\n      \"CBLB\",\n      \"PTPN22\",\n      \"DNM2\",\n      \"ZAP70\",\n      \"TAK1\",\n      \"NEMO\",\n      \"AIFM1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}